<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T02:03:57Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:10079125" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:10079125</identifier>
        <datestamp>2023-04-07</datestamp>
        <setSpec>plosone</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" dtd-version="1.3" xml:lang="en" article-type="research-article">
          <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
            <restricted-by>pmc</restricted-by>
          </processing-meta>
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">PLoS One</journal-id>
              <journal-id journal-id-type="iso-abbrev">PLoS One</journal-id>
              <journal-id journal-id-type="publisher-id">plos</journal-id>
              <journal-title-group>
                <journal-title>PLOS ONE</journal-title>
              </journal-title-group>
              <issn pub-type="epub">1932-6203</issn>
              <publisher>
                <publisher-name>Public Library of Science</publisher-name>
                <publisher-loc>San Francisco, CA USA</publisher-loc>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC10079125</article-id>
              <article-id pub-id-type="pmcid">PMC10079125</article-id>
              <article-id pub-id-type="pmc-uid">10079125</article-id>
              <article-id pub-id-type="pmid">37023031</article-id>
              <article-id pub-id-type="doi">10.1371/journal.pone.0283748</article-id>
              <article-id pub-id-type="publisher-id">PONE-D-22-35634</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Study Protocol</subject>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Surgical and Invasive Medical Procedures</subject>
                    <subj-group>
                      <subject>Abdominal Surgery</subject>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Surgical and Invasive Medical Procedures</subject>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Research and Analysis Methods</subject>
                  <subj-group>
                    <subject>Bioassays and Physiological Analysis</subject>
                    <subj-group>
                      <subject>Respiratory Analysis</subject>
                      <subj-group>
                        <subject>Spirometry</subject>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Anesthesiology</subject>
                    <subj-group>
                      <subject>Anesthesia</subject>
                      <subj-group>
                        <subject>Local and Regional Anesthesia</subject>
                        <subj-group>
                          <subject>Neuromuscular Blockade</subject>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Pharmaceutics</subject>
                    <subj-group>
                      <subject>Drug Therapy</subject>
                      <subj-group>
                        <subject>Anesthesia</subject>
                        <subj-group>
                          <subject>Local and Regional Anesthesia</subject>
                          <subj-group>
                            <subject>Neuromuscular Blockade</subject>
                          </subj-group>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Computer and Information Sciences</subject>
                  <subj-group>
                    <subject>Data Management</subject>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Physical Sciences</subject>
                  <subj-group>
                    <subject>Mathematics</subject>
                    <subj-group>
                      <subject>Statistics</subject>
                      <subj-group>
                        <subject>Statistical Data</subject>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and Life Sciences</subject>
                  <subj-group>
                    <subject>Biochemistry</subject>
                    <subj-group>
                      <subject>Biomarkers</subject>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Physical Sciences</subject>
                  <subj-group>
                    <subject>Chemistry</subject>
                    <subj-group>
                      <subject>Chemical Elements</subject>
                      <subj-group>
                        <subject>Oxygen</subject>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>An anesthesia-centered bundle to reduce postoperative pulmonary complications: The PRIME-AIR study protocol</article-title>
                <alt-title alt-title-type="running-head">The PRIME-AIR study protocol</alt-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author" corresp="yes">
                  <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-2996-7704</contrib-id>
                  <name>
                    <surname>Fernandez-Bustamante</surname>
                    <given-names>Ana</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
                  <role content-type="http://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role>
                  <role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role>
                  <role content-type="http://credit.niso.org/contributor-roles/project-administration/">Project administration</role>
                  <role content-type="http://credit.niso.org/contributor-roles/resources/">Resources</role>
                  <role content-type="http://credit.niso.org/contributor-roles/supervision/">Supervision</role>
                  <role content-type="http://credit.niso.org/contributor-roles/validation/">Validation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-original-draft/">Writing – original draft</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                  <xref rid="aff001" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                  <xref rid="cor001" ref-type="corresp">*</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Parker</surname>
                    <given-names>Robert A.</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
                  <role content-type="http://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role>
                  <role content-type="http://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role>
                  <role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role>
                  <role content-type="http://credit.niso.org/contributor-roles/project-administration/">Project administration</role>
                  <role content-type="http://credit.niso.org/contributor-roles/resources/">Resources</role>
                  <role content-type="http://credit.niso.org/contributor-roles/software/">Software</role>
                  <role content-type="http://credit.niso.org/contributor-roles/supervision/">Supervision</role>
                  <role content-type="http://credit.niso.org/contributor-roles/validation/">Validation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                  <xref rid="aff002" ref-type="aff">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Sprung</surname>
                    <given-names>Juraj</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
                  <role content-type="http://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role>
                  <role content-type="http://credit.niso.org/contributor-roles/resources/">Resources</role>
                  <role content-type="http://credit.niso.org/contributor-roles/supervision/">Supervision</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                  <xref rid="aff003" ref-type="aff">
                    <sup>3</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Eikermann</surname>
                    <given-names>Matthias</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
                  <role content-type="http://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role>
                  <role content-type="http://credit.niso.org/contributor-roles/project-administration/">Project administration</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                  <xref rid="aff004" ref-type="aff">
                    <sup>4</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-3554-883X</contrib-id>
                  <name>
                    <surname>Gama de Abreu</surname>
                    <given-names>Marcelo</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
                  <role content-type="http://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role>
                  <role content-type="http://credit.niso.org/contributor-roles/project-administration/">Project administration</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                  <xref rid="aff005" ref-type="aff">
                    <sup>5</sup>
                  </xref>
                  <xref rid="aff006" ref-type="aff">
                    <sup>6</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-1907-5323</contrib-id>
                  <name>
                    <surname>Ferrando</surname>
                    <given-names>Carlos</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
                  <role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role>
                  <role content-type="http://credit.niso.org/contributor-roles/project-administration/">Project administration</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                  <xref rid="aff007" ref-type="aff">
                    <sup>7</sup>
                  </xref>
                  <xref rid="aff008" ref-type="aff">
                    <sup>8</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Thompson</surname>
                    <given-names>B. Taylor</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
                  <role content-type="http://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role>
                  <role content-type="http://credit.niso.org/contributor-roles/project-administration/">Project administration</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                  <xref rid="aff009" ref-type="aff">
                    <sup>9</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Vidal Melo</surname>
                    <given-names>Marcos F.</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
                  <role content-type="http://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role>
                  <role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role>
                  <role content-type="http://credit.niso.org/contributor-roles/project-administration/">Project administration</role>
                  <role content-type="http://credit.niso.org/contributor-roles/resources/">Resources</role>
                  <role content-type="http://credit.niso.org/contributor-roles/supervision/">Supervision</role>
                  <role content-type="http://credit.niso.org/contributor-roles/validation/">Validation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-original-draft/">Writing – original draft</role>
                  <xref rid="aff010" ref-type="aff">
                    <sup>10</sup>
                  </xref>
                </contrib>
              </contrib-group>
              <aff id="aff001">
                <label>1</label>
                <addr-line>Department of Anesthesiology, University of Colorado School of Medicine, Aurora, CO, United States of America</addr-line>
              </aff>
              <aff id="aff002">
                <label>2</label>
                <addr-line>Biostatistics Center, Massachusetts General Hospital, Department of Medicine, Harvard Medical School, Boston, MA, United States of America</addr-line>
              </aff>
              <aff id="aff003">
                <label>3</label>
                <addr-line>Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, MN, United States of America</addr-line>
              </aff>
              <aff id="aff004">
                <label>4</label>
                <addr-line>Department of Anesthesiology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, United States of America</addr-line>
              </aff>
              <aff id="aff005">
                <label>5</label>
                <addr-line>Department of Intensive Care and Resuscitation, Anesthesiology Institute, Cleveland Clinic, Cleveland, OH, United States of America</addr-line>
              </aff>
              <aff id="aff006">
                <label>6</label>
                <addr-line>Department of Outcomes Research, Anesthesiology Institute, Cleveland Clinic, Cleveland, OH, United States of America</addr-line>
              </aff>
              <aff id="aff007">
                <label>7</label>
                <addr-line>Department of Anesthesiology and Intensive Care, Hospital Clínic Institut D’investigació August Pi i Sunyer, Barcelona, Spain</addr-line>
              </aff>
              <aff id="aff008">
                <label>8</label>
                <addr-line>CIBER de Enfermedades Respiratorias, Instituto de Salud Carlos III, Madrid, Spain</addr-line>
              </aff>
              <aff id="aff009">
                <label>9</label>
                <addr-line>Division of Pulmonary and Critical Care, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States of America</addr-line>
              </aff>
              <aff id="aff010">
                <label>10</label>
                <addr-line>Department of Anesthesiology, Columbia University Irving Medical Center, New York, NY, United States of America</addr-line>
              </aff>
              <contrib-group>
                <contrib contrib-type="editor">
                  <name>
                    <surname>Stortz</surname>
                    <given-names>Johannes</given-names>
                  </name>
                  <role>Editor</role>
                  <xref rid="edit1" ref-type="aff"/>
                </contrib>
              </contrib-group>
              <aff id="edit1">
                <addr-line>GERMANY</addr-line>
              </aff>
              <author-notes>
                <fn fn-type="COI-statement" id="coi001">
                  <p><bold>Competing Interests: </bold>AFB reports additional research funding from the US Department of Defense, the Merck Investigator-initiated Studies Program and the Institute for Healthcare Quality, Safety and Efficiency for projects unrelated to the discussed work. The rest of authors report no competing interests. This does not alter our adherence to PLOS ONE policies on sharing data and materials.</p>
                </fn>
                <corresp id="cor001">* E-mail: <email>Ana.Fernandez-Bustamante@cuanschutz.edu</email></corresp>
              </author-notes>
              <pub-date pub-type="epub">
                <day>6</day>
                <month>4</month>
                <year>2023</year>
              </pub-date>
              <pub-date pub-type="collection">
                <year>2023</year>
              </pub-date>
              <volume>18</volume>
              <issue>4</issue>
              <elocation-id>e0283748</elocation-id>
              <history>
                <date date-type="received">
                  <day>16</day>
                  <month>2</month>
                  <year>2023</year>
                </date>
                <date date-type="accepted">
                  <day>5</day>
                  <month>3</month>
                  <year>2023</year>
                </date>
              </history>
              <permissions>
                <copyright-statement>© 2023 Fernandez-Bustamante et al</copyright-statement>
                <copyright-year>2023</copyright-year>
                <copyright-holder>Fernandez-Bustamante et al</copyright-holder>
                <license>
                  <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
                  <license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
                </license>
              </permissions>
              <self-uri content-type="pdf" xlink:href="pone.0283748.pdf"/>
              <abstract>
                <sec id="sec001">
                  <title>Background</title>
                  <p>Postoperative pulmonary complications (PPCs) are a major cause of morbidity and mortality after open abdominal surgery. Optimized perioperative lung expansion may minimize the synergistic factors responsible for the multiple-hit perioperative pulmonary dysfunction. This ongoing study will assess whether an anesthesia-centered bundle focused on perioperative lung expansion results in decreased incidence and severity of PPCs after open abdominal surgery.</p>
                </sec>
                <sec id="sec002">
                  <title>Methods</title>
                  <p>Prospective multicenter randomized controlled pragmatic trial in 750 adult patients with at least moderate risk for PPCs undergoing prolonged (≥2 hour) open abdominal surgery. Participants are randomized to receive either a bundle intervention focused on perioperative lung expansion or usual care. The bundle intervention includes preoperative patient education, intraoperative protective ventilation with individualized positive end-expiratory pressure to maximize respiratory system compliance, optimized neuromuscular blockade and reversal management, and postoperative incentive spirometry and early mobilization. Primary outcome is the distribution of the highest PPC severity by postoperative day 7. Secondary outcomes include the proportion of participants with: PPC grades 1–2 through POD 7; PPC grades 3–4 through POD 7, 30 and 90; intraoperative hypoxemia, rescue recruitment maneuvers, or cardiovascular events; and any major extrapulmonary postoperative complications. Additional secondary and exploratory outcomes include individual PPCs by POD 7, length of postoperative oxygen therapy or other respiratory support, hospital resource use parameters, Patient-Reported Outcomes Measurements (PROMIS®) questionnaires for dyspnea and fatigue collected before and at days 7, 30 and 90 after surgery, and plasma concentrations of lung injury biomarkers (IL6, IL-8, RAGE, CC16, Ang-2) analyzed from samples obtained before, end of, and 24 hours after surgery.</p>
                </sec>
                <sec id="sec003">
                  <title>Discussion</title>
                  <p>Participant recruitment for this study started January 2020; results are expected in 2024. At the conclusion of this trial, we will determine if this anesthesia-centered strategy focused on perioperative lung expansion reduces lung morbidity and healthcare utilization after open abdominal surgery.</p>
                </sec>
                <sec id="sec004">
                  <title>Trial registration</title>
                  <p>ClinicalTrial.gov <ext-link xlink:href="https://clinicaltrials.gov/ct2/show/NCT04108130" ext-link-type="uri">NCT04108130</ext-link>.</p>
                </sec>
              </abstract>
              <funding-group>
                <award-group id="award001">
                  <funding-source>
                    <institution-wrap>
                      <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100017540</institution-id>
                      <institution>NHLBI Division of Intramural Research</institution>
                    </institution-wrap>
                  </funding-source>
                  <award-id>U24HL140109</award-id>
                  <principal-award-recipient>
                    <name>
                      <surname>Parker</surname>
                      <given-names>Robert A.</given-names>
                    </name>
                  </principal-award-recipient>
                </award-group>
                <award-group id="award002">
                  <funding-source>
                    <institution-wrap>
                      <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100017540</institution-id>
                      <institution>NHLBI Division of Intramural Research</institution>
                    </institution-wrap>
                  </funding-source>
                  <award-id>UH3HL140177</award-id>
                  <principal-award-recipient>
                    <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-2996-7704</contrib-id>
                    <name>
                      <surname>Fernandez-Bustamante</surname>
                      <given-names>Ana</given-names>
                    </name>
                  </principal-award-recipient>
                </award-group>
                <award-group id="award003">
                  <funding-source>
                    <institution-wrap>
                      <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100017540</institution-id>
                      <institution>NHLBI Division of Intramural Research</institution>
                    </institution-wrap>
                  </funding-source>
                  <award-id>UH3HL140177</award-id>
                  <principal-award-recipient>
                    <name>
                      <surname>Melo</surname>
                      <given-names>Marcos F. Vidal</given-names>
                    </name>
                  </principal-award-recipient>
                </award-group>
                <funding-statement>NIH/NHLBI #UH3HL140177 (AFB, MFVM) <ext-link xlink:href="https://www.nhlbi.nih.gov" ext-link-type="uri">https://www.nhlbi.nih.gov</ext-link> The Sponsor has no role in the data collection, analysis, and interpretation; preparation, review, or approval of any manuscripts submitted for publication. NIH/NHLBI #U24HL140109 (RAP) <ext-link xlink:href="https://www.nhlbi.nih.gov" ext-link-type="uri">https://www.nhlbi.nih.gov</ext-link> The Sponsor has no role in the data collection, analysis, and interpretation; preparation, review, or approval of any manuscripts submitted for publication.</funding-statement>
              </funding-group>
              <counts>
                <fig-count count="3"/>
                <table-count count="4"/>
                <page-count count="20"/>
              </counts>
              <custom-meta-group>
                <custom-meta id="data-availability">
                  <meta-name>Data Availability</meta-name>
                  <meta-value>No datasets were generated or analysed during the current study. All relevant data from this study will be made available upon study completion.</meta-value>
                </custom-meta>
              </custom-meta-group>
            </article-meta>
            <notes>
              <title>Data Availability</title>
              <p>No datasets were generated or analysed during the current study. All relevant data from this study will be made available upon study completion.</p>
            </notes>
          </front>
          <body>
            <sec sec-type="intro" id="sec005">
              <title>Introduction</title>
              <p>Postoperative pulmonary complications (PPCs) are a major cause of morbidity and mortality for patients undergoing the estimated 51 million annual inpatient surgeries in the US [<xref rid="pone.0283748.ref001" ref-type="bibr">1</xref>–<xref rid="pone.0283748.ref003" ref-type="bibr">3</xref>]. National estimates in 2011 suggested 1,062,000 PPCs per year, with 46,200 additional deaths, and 4.8 million additional days of hospitalization [<xref rid="pone.0283748.ref002" ref-type="bibr">2</xref>]. Abdominal surgery is associated with the largest absolute number of PPCs [<xref rid="pone.0283748.ref004" ref-type="bibr">4</xref>]. Whereas PPCs are as significant and lethal as cardiac surgical complications [<xref rid="pone.0283748.ref001" ref-type="bibr">1</xref>, <xref rid="pone.0283748.ref005" ref-type="bibr">5</xref>], research in the field has received much less attention, and strategies to reduce perioperative lung morbidity are limited [<xref rid="pone.0283748.ref005" ref-type="bibr">5</xref>, <xref rid="pone.0283748.ref006" ref-type="bibr">6</xref>].</p>
              <p>Prior individual approaches to optimize specific aspects of care have been pursued to reduce PPCs, mostly focused on mechanical ventilation strategies during surgery [<xref rid="pone.0283748.ref007" ref-type="bibr">7</xref>–<xref rid="pone.0283748.ref010" ref-type="bibr">10</xref>], and the optimization of the reversal of neuromuscular blockade [<xref rid="pone.0283748.ref011" ref-type="bibr">11</xref>–<xref rid="pone.0283748.ref013" ref-type="bibr">13</xref>]. During abdominal surgery, Futier <italic toggle="yes">et al</italic>. [<xref rid="pone.0283748.ref007" ref-type="bibr">7</xref>] demonstrated a reduced incidence of a composite of pulmonary complications of repeated intraoperative recruitment maneuvers, higher positive end-expiratory pressure (PEEP) 6–8 cmH<sub>2</sub>O and lower tidal volume (VT) 6–8 ml/kg of predicted body weight (PBW) <italic toggle="yes">vs</italic>. a strategy of no lung recruitments, PEEP 0 cmH<sub>2</sub>O and higher VT (10–12 ml/kgPBW). The PROVHILO study found no reduction in PPCs of intraoperative constant high (12 cmH<sub>2</sub>O) <italic toggle="yes">vs</italic>. low (≤2 cmH<sub>2</sub>O) PEEP and similar protective VT 8 ml/kgPBW in patients undergoing abdominal surgery [<xref rid="pone.0283748.ref014" ref-type="bibr">14</xref>]. While the first trial highlighted the relevance of ventilatory strategies to postoperative outcomes, the second led to the controversial recommendation that low PEEP should be the standard of care in abdominal surgery [<xref rid="pone.0283748.ref015" ref-type="bibr">15</xref>], a practice anticipated to worsen lung collapse. Individualized PEEP management has been more recently explored since the PROVHILO study. Individualized PEEP titrations can optimize lung mechanics, lung aeration or oxygenation [<xref rid="pone.0283748.ref016" ref-type="bibr">16</xref>–<xref rid="pone.0283748.ref018" ref-type="bibr">18</xref>], but they have yet failed to consistently improve relevant clinical outcomes [<xref rid="pone.0283748.ref019" ref-type="bibr">19</xref>]. PEEP optimization in most recently published studies [<xref rid="pone.0283748.ref016" ref-type="bibr">16</xref>–<xref rid="pone.0283748.ref018" ref-type="bibr">18</xref>] is typically performed once early during the surgical procedure, and the selected PEEP level remains unchanged for the rest of surgery. However, PEEP requirements for optimal lung expansion measured as respiratory system compliance vary substantially during open abdominal surgery not only among patients, but also, within the same patient, along the different phases of surgery [<xref rid="pone.0283748.ref020" ref-type="bibr">20</xref>]. Therefore, a repeated PEEP titration may be a critical intraoperative intervention to effectively achieve optimized lung expansion and improve outcomes.</p>
              <p>Other interventions during and after open abdominal surgery are likely relevant to optimize perioperative lung expansion and impact clinical outcomes. Previous reports pointed to adequate neuromuscular blockade and reversal management to improve postoperative oxygenation, minimize postoperative residual muscle weakness and optimize perioperative lung expansion [<xref rid="pone.0283748.ref011" ref-type="bibr">11</xref>–<xref rid="pone.0283748.ref013" ref-type="bibr">13</xref>]. Postoperatively, incentive spirometry followed by early ambulation are frequently employed for usual care of surgical patients as an attempt to optimize lung expansion and prevent complications after surgery [<xref rid="pone.0283748.ref005" ref-type="bibr">5</xref>, <xref rid="pone.0283748.ref021" ref-type="bibr">21</xref>–<xref rid="pone.0283748.ref024" ref-type="bibr">24</xref>]. Finally, patient education has been increasingly emphasized as essential to increase engagement with adherence and quality of performance of postoperative interventions [<xref rid="pone.0283748.ref022" ref-type="bibr">22</xref>, <xref rid="pone.0283748.ref025" ref-type="bibr">25</xref>, <xref rid="pone.0283748.ref026" ref-type="bibr">26</xref>].</p>
              <p>For the PRIME-AIR trial, we hypothesize that an intervention focused on repeated lung expansion during the perioperative period will minimize multiple and synergistic factors responsible for the multiple-hit perioperative pulmonary dysfunction and result in decreased PPCs, as well as non-pulmonary complications and healthcare utilization. To test this hypothesis, we aim to implement a bundle of perioperative interventions targeting lung expansion and composed of (1) preoperative education; intraoperative (2) repeated individualized PEEP and (3) optimized neuromuscular blockade and reversal management; and postoperative (4) incentive spirometry and (5) ambulation goals, and to assess the effect of this bundle on the incidence and severity of PPCs within postoperative day 7 as compared to usual care.</p>
            </sec>
            <sec sec-type="materials|methods" id="sec006">
              <title>Materials and methods</title>
              <p>The PRIME-AIR trial protocol is presented following the Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) 2013 and 2022 guidelines [<xref rid="pone.0283748.ref027" ref-type="bibr">27</xref>, <xref rid="pone.0283748.ref028" ref-type="bibr">28</xref>].</p>
              <sec id="sec007">
                <title>Aim, design and setting</title>
                <p>The PRIME-AIR trial is an ongoing prospective multicenter randomized controlled pragmatic trial focused on perioperative lung expansion for patients undergoing open abdominal surgery. This study aims to test if a bundle intervention focused on optimizing lung expansion before, during, and after open abdominal surgery will reduce the incidence or severity of PPCs, overall morbidity and mortality up to 90 days after surgery, and decrease plasma concentrations of biomarkers of lung injury. The trial takes place primarily at academic institutions in the United States.</p>
              </sec>
              <sec id="sec008">
                <title>Eligibility criteria</title>
                <p>We will study 750 adult patients of both genders undergoing open abdominal surgery and classified as at intermediate or high risk for PPCs.</p>
                <p>Please find <bold>inclusion and exclusion criteria</bold> in <xref rid="pone.0283748.t001" ref-type="table">Table 1</xref>. Eligible candidates are identified from the surgical schedule at participating sites, screened for inclusion and exclusion criteria, and then approached for introduction of the study and informed consent.</p>
                <table-wrap position="float" id="pone.0283748.t001">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0283748.t001</object-id>
                  <label>Table 1</label>
                  <caption>
                    <title>Inclusion and exclusion criteria of the PRIME-AIR trial.</title>
                  </caption>
                  <alternatives>
                    <graphic xlink:href="pone.0283748.t001" id="pone.0283748.t001g" position="float"/>
                    <table frame="hsides" rules="groups">
                      <colgroup span="1">
                        <col align="left" valign="middle" span="1"/>
                      </colgroup>
                      <tbody>
                        <tr>
                          <td align="left" style="background-color:#F3F3F3" rowspan="1" colspan="1">
                            <bold>Inclusion criteria</bold>
                          </td>
                        </tr>
                        <tr>
                          <td align="left" style="background-color:#F3F3F3" rowspan="1" colspan="1">    • Adults (≥18 years)<break/>    • Elective surgery with expected duration ≥2 hours<break/>    • Open abdominal surgery, including: gastric, biliary, pancreatic, hepatic, major bowel, ovarian, renal tract, bladder, prostatic, radical hysterectomy, and pelvic exenteration<break/>    • Intermediate or high risk of PPCs defined by an ARISCAT risk score ≥26 [<xref rid="pone.0283748.ref004" ref-type="bibr">4</xref>] (<xref rid="pone.0283748.s002" ref-type="supplementary-material">S1 Appendix</xref>, Table 1)</td>
                        </tr>
                        <tr>
                          <td align="left" style="background-color:#F3F3F3" rowspan="1" colspan="1">
                            <bold>Exclusion criteria</bold>
                          </td>
                        </tr>
                        <tr>
                          <td align="left" style="background-color:#F3F3F3" rowspan="1" colspan="1">    • Inability or refusal to provide consent<break/>    • Inability or significant difficulty to perform any study interventions, including incentive spirometry, ambulation and/or maintaining follow-up contact with study personnel for up to 90 days after the date of surgery<break/>    • Participation in any interventional research study within 30 days of the time of the study<break/>    • Previous surgery within 30 days prior to this study<break/>    • Pregnancy<break/>    • Emergency surgery<break/>    • Severe obesity (above Class I, BMI≥35 kg/m<sup>2</sup>)<break/>    • Significant lung disease: any diagnosed or treated respiratory condition that (a) requires home oxygen therapy or non-invasive ventilation (except nocturnal treatment of sleep apnea without supplemental oxygen), (b) severely limits exercise tolerance to &lt;4 METs (e.g., patients unable to do light housework, walk flat at 4 miles/h or climb one flight of stairs), (c) required previous lung surgery, or (d) includes presence of severe pulmonary emphysema or bullae<break/>    • Significant heart disease: cardiac conditions that limit exercise tolerance to &lt;4 METs<break/>    • Pulmonary hypertension<break/>    • Renal failure: peritoneal or hemodialysis requirement or preoperative creatinine ≥2 mg/dL<break/>    • Neuromuscular disease that impairs ability to ventilate without assistance<break/>    • Severe chronic liver disease (Child-Turcotte-Pugh Score &gt;9)<break/>    • Sepsis<break/>    • Malignancy or other irreversible condition for which 6-month mortality is estimated ≥20%<break/>    • Bone marrow transplant</td>
                        </tr>
                      </tbody>
                    </table>
                  </alternatives>
                </table-wrap>
              </sec>
              <sec id="sec009">
                <title>Interventions</title>
                <p>The study workflow diagram is shown in <xref rid="pone.0283748.g001" ref-type="fig">Fig 1</xref>. Patients are randomized to receive either usual care or an intervention bundle. Participants randomized to the usual care group receive the institution’s usual perioperative protocols of care without specific recommendations or goals. Participants randomized to the intervention group receive the intervention bundle that is summarized in the mnemonic <bold>PRIME-AIR</bold>: <bold>P</bold>EEP (positive end-expiratory pressure), <bold>R</bold>ecruitment, <bold>I</bold>ncentive spirometry, <bold>M</bold>uscle relaxant optimization, preoperative <bold>E</bold>ducation, postoperative early <bold>A</bold>mbulation, <bold>I</bold>ndividualized, and <bold>R</bold>einforced. Specifically, the intervention bundle consists of the following perioperative interventions aimed at optimizing perioperative lung expansion (see full details in the Protocol in <xref rid="pone.0283748.s002" ref-type="supplementary-material">S1 Appendix</xref>):</p>
                <list list-type="order">
                  <list-item>
                    <p>Preoperative education on PPCs and practice of lung expansion maneuvers. Participants randomized to the intervention group receive preoperative education in paper and video format that reviews relevance of PPCs, provides instructions for performing incentive spirometry, and includes study-specific postoperative incentive spirometry and daily ambulation goals. This preoperative education has been adapted from supported prior findings [<xref rid="pone.0283748.ref022" ref-type="bibr">22</xref>, <xref rid="pone.0283748.ref029" ref-type="bibr">29</xref>].</p>
                  </list-item>
                  <list-item>
                    <p>Intraoperative periodically individualized PEEP with recruitment maneuvers to maximize respiratory system compliance (Crs). Individualized PEEP is titrated to maximize Crs following previous findings [<xref rid="pone.0283748.ref020" ref-type="bibr">20</xref>] confirming that this strategy achieves increased Crs, reduced driving pressure (DP) and maintains a positive end-expiratory transpulmonary pressure (Ptp_ee) during the different phases of open abdominal surgery. Mechanical ventilation for intervention patients with volume controlled ventilation and the following settings: VT 6–8 ml/kgPBW, inspiratory to expiratory (I:E) ratio 1:2, 20% inspiratory pause, respiratory rate titrated to normocapnia and FiO<sub>2</sub> ≥0.4 aiming at SpO<sub>2</sub> ≥96%. After confirming adequate neuromuscular blockade and hemodynamic stability, a stepwise incremental PEEP recruitment maneuver is performed (i.e., PEEP = 5, 10, 15 and 20 cmH<sub>2</sub>O at 30s intervals). This is followed by a 3 cmH<sub>2</sub>O stepwise decrease in PEEP until a maximum Crs is identified (<xref rid="pone.0283748.g002" ref-type="fig">Fig 2</xref>). After a 30s recruitment maneuver to the highest recruitment PEEP, the PEEP observed for the maximum Crs is selected. This PEEP titration is performed after tracheal intubation, hourly thereafter or sooner after any event potentially associated with lung collapse such as application of surgical retractors, disconnection of the endotracheal tube, tracheal suctioning, Trendelenburg position, or if the static respiratory system compliance is reduced by ≥15%. Deviations from these recommendations are allowed and tracked at the discretion of the anesthesiologist.</p>
                  </list-item>
                  <list-item>
                    <p>Intraoperative optimized neuromuscular blockade administration and reversal based on neuromuscular monitoring. Administration of intermediate-acting neuromuscular blocking agents follows appropriate dosing recommendations (see details in <xref rid="pone.0283748.t002" ref-type="table">Table 2</xref>) and is maintained based on surgical conditions following neuromuscular transmission monitoring with 2 Hz train-of-four stimulation. At the end of surgery, neuromuscular blockade reversal is achieved following neuromuscular blockade monitoring with dosing guidelines described in <xref rid="pone.0283748.t003" ref-type="table">Table 3</xref> [<xref rid="pone.0283748.ref030" ref-type="bibr">30</xref>].</p>
                  </list-item>
                  <list-item>
                    <p>Postoperative incentive spirometry with study-specific daily goals and adherence enhanced by supervision by study personnel. Incentive spirometry instructions are based on the Guidelines of the American Association for Respiratory Care (AARC) [<xref rid="pone.0283748.ref031" ref-type="bibr">31</xref>]. Intervention patients receive: (a) specific preoperative education as described above, (b) clear expectations of incentive spirometry breaths per day (<xref rid="pone.0283748.g003" ref-type="fig">Fig 3A</xref>); and (c) direct supervision of performance by study coordinators during a target of three daily visits.</p>
                  </list-item>
                  <list-item>
                    <p>Postoperative ambulation with study-specific daily goals and adherence enhanced by encouragement by study personnel. Intervention patients receive: (a) preoperative education on the benefits of early mobilization and ambulation, (b) clear expectations of daily mobilization milestones (<xref rid="pone.0283748.g003" ref-type="fig">Fig 3B</xref>), (c) reinforcement and systematic monitoring of these milestones by study coordinators during three daily visits, and (d) encouraging patients to address barriers with care team.</p>
                  </list-item>
                </list>
                <fig position="float" id="pone.0283748.g001">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0283748.g001</object-id>
                  <label>Fig 1</label>
                  <caption>
                    <title>PRIME-AIR trial study workflow.</title>
                  </caption>
                  <graphic xlink:href="pone.0283748.g001" position="float"/>
                </fig>
                <fig position="float" id="pone.0283748.g002">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0283748.g002</object-id>
                  <label>Fig 2</label>
                  <caption>
                    <title>Diagram depicting intraoperative PEEP titration procedures for the intervention participants of the PRIME-AIR trial.</title>
                  </caption>
                  <graphic xlink:href="pone.0283748.g002" position="float"/>
                </fig>
                <fig position="float" id="pone.0283748.g003">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0283748.g003</object-id>
                  <label>Fig 3</label>
                  <caption>
                    <title>Postoperative study goals of incentive spirometry and ambulation for the intervention participants of the PRIME-AIR trial.</title>
                  </caption>
                  <graphic xlink:href="pone.0283748.g003" position="float"/>
                </fig>
                <table-wrap position="float" id="pone.0283748.t002">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0283748.t002</object-id>
                  <label>Table 2</label>
                  <caption>
                    <title>Optimized neuromuscular blockade management.</title>
                  </caption>
                  <alternatives>
                    <graphic xlink:href="pone.0283748.t002" id="pone.0283748.t002g" position="float"/>
                    <table frame="hsides" rules="groups">
                      <colgroup span="1">
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                      </colgroup>
                      <thead>
                        <tr>
                          <th align="left" colspan="3" style="background-color:#D9D9D9" rowspan="1">Maximal intubating and maintenance doses (mg/kg) of muscle relaxants to be used during the PRIME-AIR trial.<xref rid="t002fn001" ref-type="table-fn">*</xref></th>
                        </tr>
                        <tr>
                          <th align="left" rowspan="1" colspan="1"/>
                          <th align="center" rowspan="1" colspan="1">Intubation</th>
                          <th align="center" rowspan="1" colspan="1">Maintenance</th>
                        </tr>
                      </thead>
                      <tbody>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">Cisatracurium (mg/kg)</td>
                          <td align="center" rowspan="1" colspan="1">0.2</td>
                          <td align="center" rowspan="1" colspan="1">0.03</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">Rocuronium (mg/kg)</td>
                          <td align="center" rowspan="1" colspan="1">1.2</td>
                          <td align="center" rowspan="1" colspan="1">0.2</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">Vecuronium (mg/kg)</td>
                          <td align="center" rowspan="1" colspan="1">0.1</td>
                          <td align="center" rowspan="1" colspan="1">0.015</td>
                        </tr>
                      </tbody>
                    </table>
                  </alternatives>
                  <table-wrap-foot>
                    <fn id="t002fn001">
                      <p>* Maximal doses ± 20% considered acceptable due to usual concentrations of medication solutions.</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
                <table-wrap position="float" id="pone.0283748.t003">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0283748.t003</object-id>
                  <label>Table 3</label>
                  <caption>
                    <title>Optimized neuromuscular blockade reversal management.</title>
                  </caption>
                  <alternatives>
                    <graphic xlink:href="pone.0283748.t003" id="pone.0283748.t003g" position="float"/>
                    <table frame="hsides" rules="groups">
                      <colgroup span="1">
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                      </colgroup>
                      <thead>
                        <tr>
                          <th align="left" colspan="4" style="background-color:#D9D9D9" rowspan="1">Neuromuscular blockade reversal management based on monitoring of the train-of-four (TOF) ratio (T4/T1).</th>
                        </tr>
                        <tr>
                          <th align="left" colspan="2" style="background-color:#D9D9D9" rowspan="1">Twitches in the TOF</th>
                          <th align="center" rowspan="2" style="background-color:#D9D9D9" colspan="1">Neostigmine dose (mcg/kg)</th>
                          <th align="center" rowspan="2" style="background-color:#D9D9D9" colspan="1">Sugammadex dose (mg/kg)</th>
                        </tr>
                        <tr>
                          <th align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1">Quantitative Monitoring</th>
                          <th align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1">Qualitative Monitoring</th>
                        </tr>
                      </thead>
                      <tbody>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">0</td>
                          <td align="center" rowspan="1" colspan="1">0</td>
                          <td align="center" rowspan="1" colspan="1">Wait</td>
                          <td align="center" rowspan="1" colspan="1">Wait or 4–16</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">1</td>
                          <td align="center" rowspan="1" colspan="1">1</td>
                          <td align="center" rowspan="1" colspan="1">Wait</td>
                          <td align="center" rowspan="1" colspan="1">3–4</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">2–3</td>
                          <td align="center" rowspan="1" colspan="1">2–3</td>
                          <td align="center" rowspan="1" colspan="1">50</td>
                          <td align="center" rowspan="1" colspan="1">2–3</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">T4/T1&lt;0.4</td>
                          <td align="justify" rowspan="1" colspan="1">4 with fade</td>
                          <td align="center" rowspan="1" colspan="1">40</td>
                          <td align="center" rowspan="1" colspan="1">1–2</td>
                        </tr>
                        <tr>
                          <td align="justify" rowspan="1" colspan="1">T4/T1 = 0.4–0.9</td>
                          <td align="center" rowspan="1" colspan="1">4 without fade</td>
                          <td align="center" rowspan="1" colspan="1">15–25</td>
                          <td align="center" rowspan="1" colspan="1">0.25–2</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">T4/T1&gt;0.9</td>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="justify" rowspan="1" colspan="1">Unnecessary</td>
                          <td align="left" rowspan="1" colspan="1">Unnecessary</td>
                        </tr>
                      </tbody>
                    </table>
                  </alternatives>
                </table-wrap>
                <p>Intraoperative care to intervention participants is provided by anesthesiologists that have been randomized and trained in the study protocol (“intervention anesthesiologists”), while control group participants receive care by anesthesiologists that have been randomized to provide usual care (“control anesthesiologists”). Anesthesiologists are randomized at each site and may be stratified by frequency of anesthesiology practice for open abdominal surgery. Participants randomized to the control group receive usual care during surgery as per their medical anesthesia team.</p>
                <p>Postoperative daily visits for all participants by study coordinators are maintained until hospital discharge, postoperative day 7, or when they are fully ambulatory. Full ambulation is defined as the ability to be out of bed for at least 6 hours/day and walk at least 75 meters 3 times/day. Intervention participants receive focused supervision of incentive spirometry, and review and encouragement of daily lung expansion (incentive spirometry and ambulation) study goals (<xref rid="pone.0283748.g003" ref-type="fig">Fig 3</xref>). Control participants receive daily postoperative visits with generic conversation by study coordinators.</p>
                <p>All participants have a blood sample collected before surgery, at the end of surgery (extubation or equivalent) and 24 hours after the end of surgery. These blood samples will be used for analysis of concentrations of lung injury biomarkers and for the development of a biorepository of perioperative blood samples from patients undergoing open abdominal surgery at risk for PPCs.</p>
                <sec id="sec010">
                  <title>Outcomes</title>
                  <p>All outcomes for each participant are assessed by a blinded investigator.</p>
                </sec>
              </sec>
              <sec id="sec011">
                <title>Primary outcome</title>
                <p>For an individual participant, the primary outcome is the participant’s PPC severity within postoperative day 7. We utilize an established scale of PPC severity classified from none (Grade 0) to Grade 4 [<xref rid="pone.0283748.ref007" ref-type="bibr">7</xref>, <xref rid="pone.0283748.ref032" ref-type="bibr">32</xref>, <xref rid="pone.0283748.ref033" ref-type="bibr">33</xref>] modified to include PPCs defined in recent large trials [<xref rid="pone.0283748.ref004" ref-type="bibr">4</xref>, <xref rid="pone.0283748.ref019" ref-type="bibr">19</xref>] (<xref rid="pone.0283748.t004" ref-type="table">Table 4</xref>). These modifications aim to maximize event detection through the addition of two items into the grading scale: (a) Mild hypoxemia (Grade 1), a usual clinical trigger for oxygen therapy in acute patients, associated by us and others with clinically meaningful outcomes and health care utilization [<xref rid="pone.0283748.ref019" ref-type="bibr">19</xref>, <xref rid="pone.0283748.ref034" ref-type="bibr">34</xref>, <xref rid="pone.0283748.ref035" ref-type="bibr">35</xref>]; and (b) Respiratory infection (Grade 2), included as an important complication in recent large studies on PPCs with a broad definition [<xref rid="pone.0283748.ref004" ref-type="bibr">4</xref>, <xref rid="pone.0283748.ref014" ref-type="bibr">14</xref>, <xref rid="pone.0283748.ref036" ref-type="bibr">36</xref>]. By using the highest PPC grade as the primary outcome in each participant, we seek to detect the impact of the bundle on both the overall PPC rate and on the severity of occurring PPCs (see Data Analysis section). The 7-day postoperative period was chosen because it includes the majority of PPCs occurring within the first month after surgery [<xref rid="pone.0283748.ref007" ref-type="bibr">7</xref>], has been used in previous large trials [<xref rid="pone.0283748.ref007" ref-type="bibr">7</xref>, <xref rid="pone.0283748.ref014" ref-type="bibr">14</xref>] and is known to prolong hospital length of stay [<xref rid="pone.0283748.ref034" ref-type="bibr">34</xref>, <xref rid="pone.0283748.ref037" ref-type="bibr">37</xref>].</p>
                <table-wrap position="float" id="pone.0283748.t004">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0283748.t004</object-id>
                  <label>Table 4</label>
                  <caption>
                    <title>Definitions for postoperative pulmonary complications (PPCs) for the PRIME-AIR trial (adjusted from Futier <italic toggle="yes">et al</italic>. [<xref rid="pone.0283748.ref007" ref-type="bibr">7</xref>]).</title>
                  </caption>
                  <alternatives>
                    <graphic xlink:href="pone.0283748.t004" id="pone.0283748.t004g" position="float"/>
                    <table frame="hsides" rules="groups">
                      <colgroup span="1">
                        <col align="left" valign="middle" span="1"/>
                      </colgroup>
                      <tbody>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>Grade 1</bold>
                          </td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"><underline>Mild hypoxemia:</underline> SpO<sub>2</sub> = 90–92% on room air or the equivalent imputed PaO<sub>2</sub>/FiO<sub>2</sub> ratio when oxygen therapy is provided<break/><underline>Mild respiratory findings:</underline> abnormal lung symptoms/signs (e.g., cough, dyspnea) and temperature &gt;37.5°C without other documented cause; chest radiograph normal/unavailable</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>Grade 2</bold>
                          </td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"><underline>Cough</underline>: productive, no other cause<break/><underline>Bronchospasm</underline>: new or pre-existent wheezing resulting in therapy change<break/><underline>Hypoxemia:</underline> PaO<sub>2</sub>&lt;60 mmHg or SpO<sub>2</sub>&lt; 90% on room air or the equivalent imputed PaO<sub>2</sub>/FiO<sub>2</sub> ratio when oxygen therapy is provided<break/><underline>Respiratory Infection:</underline> use of antibiotic for suspected respiratory infection and at least one of the following: new or changed sputum, fever&gt;37.5°C, WBC&gt;12,000/mm<sup>3</sup><break/><underline>Atelectasis*</underline>: radiological confirmation + either temperature &gt;37.5°C or abnormal lung symptoms/signs (e.g., cough, dyspnea)<break/><underline>Hypercarbia</underline>: transient, requiring treatment</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>Grade 3</bold>
                          </td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"><underline>Pleural effusion</underline>: resulting in thoracentesis<break/><underline>Pneumonia</underline>**, suspected: radiological evidence without bacteriological confirmation<break/><underline>Pneumonia**</underline>, proved: radiological evidence and documentation of pathological organism<break/><underline>Pneumothorax: resulting in intervention.</underline><break/><underline>Ventilatory dependence:</underline> (non-invasive or invasive ventilation) &lt; 48h</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>Grade 4</bold>
                          </td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"><underline>Ventilatory failure</underline>: postoperative non-invasive or invasive ventilation dependence ≥48h</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"><bold>* Atelectasis:</bold> lung opacification with shift of the mediastinum, hilum or hemidiaphragm towards affected area and compensatory overinflation. ** <bold>Pneumonia:</bold> new and/or progressive pulmonary infiltrates on chest X-ray and two or more of: fever ≥38°C or hypothermia (&lt;36°C); white blood cell count (WBC)/mm<sup>3</sup>&gt;12000 or &lt;4000; purulent sputum and/or onset or worsening cough or dyspnea.</td>
                        </tr>
                      </tbody>
                    </table>
                  </alternatives>
                </table-wrap>
              </sec>
              <sec id="sec012">
                <title>Secondary outcomes</title>
                <p>For the study include the proportion of participants with highest PPC grade as Grades 1–2 through POD 7; PPC Grades 3–4 through POD 7, 30 and 90; hypoxemia, atelectasis, pneumonia or ventilatory requirement by POD 7; intraoperative hypoxemia and rescue recruitment maneuvers; intraoperative cardiovascular events; and any major extrapulmonary postoperative complication. Secondary outcomes for the study also include the median length of postoperative oxygen therapy or other respiratory support and length of hospital stay. See details and definitions in the Protocol in <xref rid="pone.0283748.s002" ref-type="supplementary-material">S1 Appendix</xref>.</p>
                <p>Additional <bold>Exploratory Outcomes</bold> are listed in the Protocol in <xref rid="pone.0283748.s002" ref-type="supplementary-material">S1 Appendix</xref>, and encompass mortality, frequency of individual pulmonary and extra-pulmonary complications, residual muscle weakness, doses of intraoperative vasoactive medications and fluids, other hospital resources used (e.g., unplanned ICU admission, post-discharge disposition, readmissions), and PROMIS® questionnaire scores.</p>
              </sec>
              <sec id="sec013">
                <title>Plasma concentrations of biomarkers</title>
                <p>To test the hypothesis that the PRIME-AIR bundle intervention will minimize lung mechanical injury and inflammation by reducing overinflation and atelectasis, we will compare plasma biomarker concentrations in the PRIME-AIR intervention <italic toggle="yes">vs</italic>. control groups before, at the end of and 24h after surgery. We will include plasma biomarkers of inflammation (cytokines IL-6, IL-8), epithelial injury (the soluble form of the receptor for advanced glycation end-products, RAGE, and club cell protein 16, CC16), and endothelial injury (angiopoietin-2, Ang-2) [<xref rid="pone.0283748.ref038" ref-type="bibr">38</xref>–<xref rid="pone.0283748.ref040" ref-type="bibr">40</xref>]. Blood collection in this aim will not only allow for the biomarkers analysis, but also for the creation of a biobank for future studies on PPCs.</p>
              </sec>
              <sec id="sec014">
                <title>Participant timeline</title>
                <p>Patient enrollment is currently ongoing and expected to reach the 750 studied patient goal no later than summer 2023.</p>
              </sec>
              <sec id="sec015">
                <title>Sample size</title>
                <p>Sample size was estimated using simulations of the primary analysis of the distribution of highest PPC severity between the two groups. Based on these simulations, our sample size of 375/group (750 total) being studied has 93% power (α = 0.05, two-sided) for the primary analysis for the study. We formulated the treatment effect in this project as a relative percent reduction in PPC rate between groups, not an absolute difference between the two groups. For simplicity in these simulations, we assumed no change in the distribution of the severity of PPCs, so the reduction in PPC rate applied to the number of PPCs of each severity grade. The number of participants without any PPC (highest severity PPC grade 0) was then adjusted accordingly. We then assumed a PPC event rate in the usual care group of 40% [<xref rid="pone.0283748.ref007" ref-type="bibr">7</xref>, <xref rid="pone.0283748.ref014" ref-type="bibr">14</xref>, <xref rid="pone.0283748.ref019" ref-type="bibr">19</xref>, <xref rid="pone.0283748.ref034" ref-type="bibr">34</xref>], and a treatment effect (relative reduction of PPC rate) of 35.29% (so an absolute PPC event rate of 25.88% in the group receiving the intervention bundle). The 35.29% reduction in the rate of any PPCs was the lower 10% bound (one-sided) of the highest posterior region based on previous studies using a Bayesian analysis. This means that we have a 90% expectation that the true treatment effect (reduction in the overall rate of PPCs) of the entire bundle would be greater than 35.29%. We assumed for the simulations that among participants with PPCs, approximately 50% would be grade 1, 25% grade 2, 20% grade 3, and 5% grade 4.</p>
              </sec>
              <sec id="sec016">
                <title>Recruitment</title>
                <p>Potential candidates are identified from the surgical schedule at individual sites, based on type and estimated duration of surgical procedure. Medical records are reviewed to ensure that participants meet inclusion/exclusion criteria. Candidates are then approached for introduction of the PRIME-AIR trial by phone, videoconference (telehealth), or in person during a preoperative hospital visit. All research personnel approaching potential participants have appropriate human subjects research training per institutional requirements (e.g., Collaborative Institutional Training Initiative (CITI Program) training) and study training.</p>
              </sec>
              <sec id="sec017">
                <title>Allocation</title>
                <p>Randomization is performed through the PRIME-AIR online randomization system (RS). Randomization at each site is blocked over time. Only site is used as a stratification factor.</p>
              </sec>
              <sec id="sec018">
                <title>Blinding</title>
                <p>The intraoperative and postoperative study interventions cannot be blinded. At each site, an unblinded investigator performs the participant’s randomization, education, and postoperative incentive spirometry/mobilization encouragement during hospital visits. An anesthesiologist assigned to the appropriate group implements the intervention in the operating room. An investigator blinded to patient allocation assesses PPCs and all other participant outcomes with information obtained from the participant’s medical chart and the participant via phone calls, videoconference or in person visits. Investigators performing biomarker assays will also be blinded to study group allocation.</p>
              </sec>
              <sec id="sec019">
                <title>Data collection</title>
                <p>These include preoperative demographics, comorbidities, details related to the surgical procedure (e.g., duration, type), vital signs, periodic ventilator settings, medications and fluids received during surgery, parameters related to the postoperative course (e.g., admission to the Intensive Care Unit, length of stay, clinical events within postoperative days 7, 30 and 90) and Patient-Reported Outcomes Measurement Information System (PROMIS®) short questionnaires of fatigue (Short Form 13a) and dyspnea (Short Form 10a) preoperatively and on postoperative days 7, 30 and 90. Details and definitions are included in the Protocol in <xref rid="pone.0283748.s002" ref-type="supplementary-material">S1 Appendix</xref>. Data collection (directly from participants and from their electronic medical records) is required for any participants that experience a deviation from the bundle intervention unless they withdraw their consent to data collection.</p>
              </sec>
              <sec id="sec020">
                <title>Data management</title>
                <p>Data is entered in the PRIME-AIR StudyTRAX database (ScienceTrax, LLC, Macon GA) which consists of separate projects for screening, unblinded data collection and blinded data collection. Access to specific projects is restricted to trained study team members at the site filling the role. Access is also available to members of the Statistical and Data Coordinating Center. Data is queried for completeness and validity. Missing data is minimized by allowing collection from medical records for certain variables. As we anticipate missing data on less than 1% of participants for the primary endpoint, no data imputation for missing data will be done.</p>
              </sec>
              <sec id="sec021">
                <title>Data analysis plan</title>
                <p>The primary analysis will use a Cochran-Mantel Haenszel test (specifically the row mean score test), stratifying by site. This tests the null hypothesis that there is no difference between the two treatment groups in the distribution of the highest PPC grade during the first seven days of the study. The alternative hypothesis is that there is a difference between the two treatment groups in the distribution of the most severe PPC grade during the first seven days of the study. The results of this test will determine whether the study can claim that the intervention bundle reduced the average level of PPC severity. Secondary outcomes will be analyzed depending on the type of variable (see Table 6 of Protocol in <xref rid="pone.0283748.s002" ref-type="supplementary-material">S1 Appendix</xref>). More complex modeling approaches will be used to explore the results in more detail.</p>
              </sec>
              <sec id="sec022">
                <title>Data monitoring</title>
                <p>A Data Safety Monitoring Board (DSMB) has been established by the Sponsor, the National Heart, Lung and Blood Institute at the National Institutes of Health (NIH/NHLBI), and a Medical Monitor has been appointed by the study’s Executive Committee. The DSMB and the Medical Monitor are independent of the Study Management Committee and the Sponsor. The Medical Monitor receives information regarding all Adverse Events and provides advice on their possible relatedness to the study. The DSMB met prior to start of study to review and approve the protocol and approves all protocol amendments.The DSMB meets every 6 months during study enrollment with the Medical Monitor and the Study Management Committee. During these meetings, the DSMB receives updated reports of study data, interim data analyses as planned, and safety information (e.g., Adverse Events). Serious Adverse Events are reported to the DSMB within 24 hours (fatal events) or within 7 days (nonfatal events) of their notification to the Statistical and Data Coordinatng Center.</p>
              </sec>
              <sec id="sec023">
                <title>Interim analysis</title>
                <p>Interim analysis uses a Haybittle-Peto boundary (P&lt;0.001) for the primary endpoint. Data is analyzed as described above and provided to the DSMB. There will be two interim analyses for efficacy (at approximately 250 and 500 participants with available data), and a futility analysis was planned for the second timepoint.</p>
              </sec>
              <sec id="sec024">
                <title>Self-auditing</title>
                <p>Sites engage in a self-assessment with at least 5 participants (or 10% of those recruited by the respective site), where a coordinator not involved in the primary data collection re-extracts the data from the EMR. Data is checked for consistency between the primary data collected and the self-assessment. Discrepancies are resolved by the site PI. Depending on the results of this review process, the Study Management Committee decides if data quality is adequate or not, in which case they can request a self-assessment of 5 additional participants from that site or an internal review (by the site) of all their data of a particular type. If there were major issues, a source document verification, remote monitoring or even an in-person visit may be recommended.</p>
              </sec>
              <sec id="sec025">
                <title>Research ethics approval</title>
                <p>The Protocol and informed consent forms included in the Appendix have been approved by the Partners Human Research Institutional Review Board (protocol# 2019P001788, original approval date 8/20/2019). The Partners Human Research Institutional Review Board acts as the single Institutional Review Board (sIRB) for all sites except for a Veterans Administration (VA) facility reviewed by their own IRB. The single IRB approved the protocol, site-specific informed consent forms, materials for participant recruitment, and study participant documents (e.g., preoperative education, postoperative study milestones). Annual reviews and any protocol modifications are also submitted for review and approval by the sIRB and the Miami VA IRB. Routine reports to the sIRB include the total number of participants enrolled, summaries of participants characteristics, outcomes, and adverse events, and summaries of each DSMB review of safety and/or efficacy.</p>
              </sec>
              <sec id="sec026">
                <title>Protocol amendments</title>
                <p>Formal amendments to the protocol will be pursued for any modifications to the protocol affecting participant eligibility, study objectives or any significant administrative study aspect or study procedure. Any protocol amendments considered necessary by the Study Management Committee or requested by the DSMB will be approved by such DSMB and the appropriate IRB(s) prior to the implementation of any changes. An important protocol adjustment was obtained in the spring of 2020 to allow minimizing in person contact for the extenuating circumstances surrounding the COVID-19 pandemic [<xref rid="pone.0283748.ref041" ref-type="bibr">41</xref>]. The COVID-19 pandemic caused a substantial impact on the PRIME-AIR trial due to delays and cancellations of elective surgical procedures and unprecendented efforts to minimize transmission of viral infections between patients, healthcare personnel and clinical research members. The PRIME-AIR trial had to pause enrollment from March 2020 to July 2020. Recruitment resumed when permitted by each site. Protocol study modifications were guided by individual institutional recommendations and reviewed and approved by the sIRB in June 2020. These modifications included electronic informed consent processes and different types of Health Insurance Portability and Accountability Act (HIPPA)-approved virtual contact strategies (institutional tele-health or videoconference platforms) between study participants and investigators.</p>
              </sec>
              <sec id="sec027">
                <title>Consent or assent</title>
                <p>Participant identification and screening may be done from pre-admission/anesthesia clinic schedules (manual or electronic), surgeons’ office schedules, operating room schedules and by communication with relevant nursing and medical staff, depending on site preferences. Once subjects are identified as meeting inclusion and exclusion criteria, they are contacted according to each site’s procedures including approaches such as in person during hospital clinic visits, phone call or videoconference through a site-specific approved HIPAA-compliant telemedicine videoconferencing platform. Research personnel (research coordinators or research nurses) at each site introduces the PRIME-AIR trial to the subject. If the subject is interested in receiving further information, the site provides a written consent containing that information in person, by mail, or email. A follow-up telephone call is done to discuss any questions or concerns the subject may have. After those are addressed and if the subject agrees to participate, a signed informed consent is obtained in person or by a site-specific HIPPA-compliant eConsent process. If none of these options are feasible until the day of surgery, the sIRB has allowed that the subject has the option to verbally agree to participate and sign the informed consent on the day of surgery. This verbal agreement to participate is needed to allow randomization of study participants before the day of surgery and assign an anesthesiologist for the appropriate study group. An independent consent section is required for the sharing of biological specimens and data with the NHLBI BioLINCC repository.</p>
              </sec>
              <sec id="sec028">
                <title>Confidentiality</title>
                <p>Study-related information is stored at each study site following secure local and sIRB-guided regulations for clinical research data, with participant protected health information stored in locked file cabinets in areas with access restricted to study personnel. All participant data collection reports and laboratory specimens are identified by a study-specific identification code number to maintain participant confidentiality. The individual sites but not the Statistical and Data Coordinating Center have access to participants names and contact information. Study data from all participants is entered by site study personnel using the participant’s study code number into a central, study-specific and password-protected commercial online database (StudyTRAX) provided by the Statistical and Data Coordinating Center. Dates and site name are included in the PRIME-AIR online database. No identifiable information is shared in any reports from the Statistical and Data Coordinating Center, communications to the sIRB or DSMB, or any publications.</p>
              </sec>
              <sec id="sec029">
                <title>Access to data</title>
                <p>The Statistical and Data Coordinating Center will oversee the data sharing process until data sets are submitted to the NIH/NHLBI repository. Site investigators always have access to their own data. Primary data is stored in the StudyTRAX data managment system, which limits access to authorized users for specific sites / types of data (e.g. blinded coordinators only have access to the blinded and screening data at their own site). The Clinical Coordinating Principal Investigators will have access to all cleaned data for the study; this would be provided in password protected files of an appropriate format (e.g. SAS datasets) as requested by the individual. Writing groups for specific papers will have access to the data used in the manuscript (again, password protected, in a format agreed with the writing group) To ensure confidentiality, data from multiple sites shared with writing groups and other study team members outside the Study Management Committee will be deidentified of any PHI, with date of surgery specified by month/year only, and all other dates converted to days before/after surgery.</p>
                <p>We will comply with all data sharing and dissemination requirements on the NIH Policy on the Dissemination of NIH-Funded Clinical Trial Information (Notice Number: NOT-OD-16-149). This includes registration of the study in the required time frame and submitting results to ClinicalTrials.gov within 12 months of the date of final collection for the primary endpoint as required by these regulations. We will submit our data and specimens to the NHLBI BioLINCC repository (or a successor repository) for those participants that opted to participate in this NHLBI BioLINCC biorepository. Our data and specimen sharing plan will be consistent with NIH and NHLBI guidelines in effect at the time we are preparing the transfer.</p>
              </sec>
              <sec id="sec030">
                <title>Ancillary and post-trial care</title>
                <p>All intervention components of the PRIME-AIR trial are included within the standard of care principles for surgical patients. If any incidental findings are discovered from participants’ interactions with the research team during any phases of the study, they will be communicated to the participant’s primary medical team as appropriate for further care.</p>
              </sec>
              <sec id="sec031">
                <title>Dissemination policy</title>
                <p>We will prioritize timely dissemination of the results of the PRIME-AIR study to ensure that results are widely available for clinical practice. The Scientific Dissemination Committee will direct the dissemination activities and determine authorship eligibility following accepted medical peer-review guidelines [<xref rid="pone.0283748.ref042" ref-type="bibr">42</xref>]. No professional writers will be used. Three levels of dissemination are planned, including: 1) health care providers, 2) the scientific community, and 3) the general public. We have already opened a dedicated website (<ext-link xlink:href="http://www.primeairstudy.org/" ext-link-type="uri">www.primeairstudy.org</ext-link>). The PRIME-AIR study website will initially contain information on study goals, study design, participating institutions and scientists. After the results have been published, the website will contain the detailed results of the PRIME-AIR study. Results will also be presented at medical local, national and international meetings. We anticipate the submission of the primary manuscript within a few months after the last visit of the last patient, and multiple secondary manuscripts containing a priori secondary analyses subsequently.</p>
                <p>We will also comply with all requirements on the NIH Policy on the Dissemination of NIH-Funded Clinical Trial Information, which includes registration of the study and submitting results to ClinicalTrials.gov within the appropriate time frames. We will submit our data and specimens to the NHLBI BioLINCC repository and follow their required procedures at the end of the study.</p>
              </sec>
            </sec>
            <sec sec-type="conclusions" id="sec032">
              <title>Discussion</title>
              <p>The PRIME-AIR trial has been designed to address the primary hypothesis of whether a perioperative lung expansion bundle intervention can reduce the frequency and/or severity of PPCs within postoperative day 7 after ≥2h-long open abdominal surgery in patients with at least moderate risk for PPCs, compared to usual care. Reducing the pulmonary morbidity is a critical need for patients after open abdominal surgery. The potential of the PRIME-AIR study to improve pulmonary outcomes with interventions that are well known and do not increase healthcare costs has a clear clinical value. Importantly, the PRIME-AIR trial will provide very granular information related to the frequency and severity of PPCs in academic medical centers. Data will include mild complications that have not been studied prospectively in detail (e.g., mild hypoxemia, mild respiratory symptoms) and their association with healthcare resources use and outcomes up to 3 months after surgery.</p>
              <p>The PRIME-AIR bundle intervention includes preoperative patient education, intraoperative PEEP titration and optimized neuromuscular blockade and reversal management, and postoperative incentive spirometry and early ambulation. These pragmatic interventions constitute best care practices of perioperative care and do not introduce new procedures, but they emphasize and reinforce strategies already familiar to clinicians. Detailed data collection from the PRIME-AIR trial will provide insight on the effect of the individual bundle components on postoperative pulmonary outcomes. This is particularly important because the implementation of these best care practices is time consuming to healthcare personnel and is inconsistently followed by providers and patients.</p>
              <p>Of note, findings from the PRIME-AIR trial will be valuable independent of the primary results. This large multicenter study will provide comprehensive information on patients undergoing open abdominal surgery from varied academic US medical centers to characterize in-depth not only pulmonary complications up to 90 days after surgery, but also extra-pulmonary outcomes and validated Patient-Reported Outcome Measurements (PROMIS®). We will obtain extensive details about key aspects of care process for abdominal surgery at US academic centers, including those pertaining to anesthesia-centered perioperative care (e.g., neuromuscular blockade and reversal, analgesia strategies and opioid consumption), as well as postoperative care and hospital resources use after abdominal surgery (e.g., incentive spirometry and ambulation, hospital length of stay or readmissions up to 90 postoperative days). In addition, we will understand details related to patient adherence with postoperative lung expansion recommendations of incentive spirometry and ambulation. The analysis of plasma concentrations of accepted lung injury biomarkers may suggest mechanistic pathways associated with perioperative lung expansion and postoperative pulmonary or extra-pulmonary complications. Finally, the PRIME-AIR trial has consolidated the creation of the Perioperative Research Network (PRN), a diverse group of academic anesthesiologists and investigators focused on perioperative research and outcomes. Various secondary analyses and ancillary studies have been discussed and are being planned for additional questions that benefit from the original dataset.</p>
              <p>It is possible that results from the PRIME-AIR trial cannot be generalized to other surgical populations with lower risk for PPCs. The PRIME-AIR study does not enroll patients undergoing emergency, elective laparoscopic or short open abdominal or non-abdominal surgical procedures. Therefore study findings will have to be confirmed in those populations separately. Also, the effectiveness of the individual PRIME-AIR bundle intervention components may depend on quality of implementation of perioperative intervention components and on participant’s adherence to postoperative study goals. Data related to those variables (e.g., quality of implementation, patient adherence) are collected during the trial to provide an assessment of the impact of these aspects on the incidence and severity of PPCs. Lastly, the participating sites are all large US academic centers. As a consequence, usual care in those institutions may not represent the typical care in community hospitals thoughout the nation or outside the US.</p>
              <p>Results from the ongoing PRIME-AIR study are expected to be available in 2024. We are confident that the PRIME-AIR trial will provide a wealth of information relevant to postoperative pulmonary mobidity after abdominal surgery.</p>
            </sec>
            <sec id="sec033" sec-type="supplementary-material">
              <title>Supporting information</title>
              <supplementary-material id="pone.0283748.s001" position="float" content-type="local-data">
                <label>S1 Checklist</label>
                <caption>
                  <title>SPIRIT checklist (combined SPIRIT 2013 and SPIRIT-Outcomes 2022 items).</title>
                  <p>(DOCX)</p>
                </caption>
                <media xlink:href="pone.0283748.s001.docx">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material id="pone.0283748.s002" position="float" content-type="local-data">
                <label>S1 Appendix</label>
                <caption>
                  <p>(PDF)</p>
                </caption>
                <media xlink:href="pone.0283748.s002.pdf">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
            </sec>
          </body>
          <back>
            <ack>
              <p>List of all PRN investigators names (in alphabetical order) and affiliations:</p>
              <p>David Amar, M.D.<sup>1</sup></p>
              <p>Karsten Bartels, M.D., PhD.<sup>2</sup></p>
              <p>James Blum, M.D.<sup>3</sup></p>
              <p>Lee-Lynn Chen, M.D.<sup>4</sup></p>
              <p>Dawn Desiderio, M.D.<sup>1</sup></p>
              <p>David Josh Douin, M.D.<sup>5</sup></p>
              <p>Matthias Eikermann, M.D., Ph.D.<sup>6</sup></p>
              <p>Ana Fernandez-Bustamante, M.D., Ph.D.<sup>5</sup></p>
              <p>Gyorgy Frendl, M.D., Ph.D.<sup>7</sup></p>
              <p>Marcelo Gama de Abreu, M.D., M.Sc., Ph.D., D.E.S.A.<sup>8</sup></p>
              <p>Jadelis Giquel, M.D.<sup>9</sup></p>
              <p>Loreta Grecu, M.D.<sup>10</sup></p>
              <p>Ravindra Alok Gupta, M.D.<sup>11</sup></p>
              <p>Suzanne Karan, M.D.<sup>12</sup></p>
              <p>Daryl J. Kor, M.D.<sup>13</sup></p>
              <p>Jae-Woo Lee, M.D., Ph.D.<sup>4</sup></p>
              <p>Ricardo Martinez Ruiz, M.D.<sup>14</sup></p>
              <p>Nitin Mehdiratta, M.D.<sup>10</sup></p>
              <p>Guido Musch, M.D., M.B.A.<sup>15</sup></p>
              <p>Jacob Nadler, M.D., Ph.D.<sup>12</sup></p>
              <p>Alexander Nagrebetsky, M.D., M.Sc.<sup>16</sup></p>
              <p>Robert A. Parker, Sc.D.<sup>16</sup></p>
              <p>Juraj Sprung, M.D., Ph.D.<sup>13</sup></p>
              <p>Balachundhar Subramaniam, M.D.<sup>17</sup></p>
              <p>Alissa Sodickson, M.D.<sup>7</sup></p>
              <p>Pedro Tanaka, M.D., Ph.D.<sup>18</sup></p>
              <p>B. Taylor Thompson, M.D.<sup>16</sup></p>
              <p>Arnaldo Vera Arroyo, M.D.<sup>9</sup></p>
              <p>Marcos Francisco Vidal Melo, M.D., Ph.D.<sup>19</sup></p>
              <p>Gebhard Wagener, M.D.<sup>19</sup></p>
              <p>Jonathan P. Wanderer, M.D.<sup>20</sup></p>
              <p>Toby N. Weingarten, M.D.<sup>13</sup></p>
              <p>Affiliations:</p>
              <p><sup>1</sup> Memorial Sloan Kettering Cancer Center, New York, NY.</p>
              <p><sup>2</sup> University of Nebraska Medical Center, Omaha, NE.</p>
              <p><sup>3</sup> University of Iowa, Iowa City, IA.</p>
              <p><sup>4</sup> University of California San Francisco, San Francisco, CA.</p>
              <p><sup>5</sup> University of Colorado School of Medicine, Aurora, CO.</p>
              <p><sup>6</sup> Montefiore Medical Center, New York, NY.</p>
              <p><sup>7</sup> Brigham and Women’s Hospital, Boston, MA.</p>
              <p><sup>8</sup> Cleveland Clinic, Cleveland, OH.</p>
              <p><sup>9</sup> University of Miami, Palmetto Bay, FL.</p>
              <p><sup>10</sup> Duke University School of Medicine, Durham, NC.</p>
              <p><sup>11</sup> Northwestern Medicine, Chicago, IL.</p>
              <p><sup>12</sup> University of Rochester Medical Center, Rochester, NY.</p>
              <p><sup>13</sup> Mayo Clinic, Rochester, MN.</p>
              <p><sup>14</sup> NCH Heart Institute, Naples, FL.</p>
              <p><sup>15</sup> University of Massachusetts, Worcester, MA.</p>
              <p><sup>16</sup> Massachusetts General Hospital, Boston, MA.</p>
              <p><sup>17</sup> Beth Israel Deaconess Medical Center, Boston, MA.</p>
              <p><sup>18</sup> Stanford University, Stanford, CA.</p>
              <p><sup>19</sup> Columbia University Irving Medical Center, New York, NY.</p>
              <p><sup>20</sup> Vanderbilt University Medical Center, Nashville, TN.</p>
            </ack>
            <ref-list>
              <title>References</title>
              <ref id="pone.0283748.ref001">
                <label>1</label>
                <mixed-citation publication-type="journal"><name><surname>Lawrence</surname><given-names>VA</given-names></name>, <name><surname>Hilsenbeck</surname><given-names>SG</given-names></name>, <name><surname>Mulrow</surname><given-names>CD</given-names></name>, <name><surname>Dhanda</surname><given-names>R</given-names></name>, <name><surname>Sapp</surname><given-names>J</given-names></name>, <name><surname>Page</surname><given-names>CP</given-names></name>. <article-title>Incidence and hospital stay for cardiac and pulmonary complications after abdominal surgery</article-title>. <source>Journal of general internal medicine</source>. <year>1995</year>;<volume>10</volume>(<issue>12</issue>):<fpage>671</fpage>–<lpage>8</lpage>. Epub 1995/12/01. <comment>doi: </comment><pub-id pub-id-type="doi">10.1007/BF02602761</pub-id> .<?supplied-pmid 8770719?><pub-id pub-id-type="pmid">8770719</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0283748.ref002">
                <label>2</label>
                <mixed-citation publication-type="journal"><name><surname>Shander</surname><given-names>A</given-names></name>, <name><surname>Fleisher</surname><given-names>LA</given-names></name>, <name><surname>Barie</surname><given-names>PS</given-names></name>, <name><surname>Bigatello</surname><given-names>LM</given-names></name>, <name><surname>Sladen</surname><given-names>RN</given-names></name>, <name><surname>Watson</surname><given-names>CB</given-names></name>. <article-title>Clinical and economic burden of postoperative pulmonary complications: patient safety summit on definition, risk-reducing interventions, and preventive strategies.</article-title><source>Crit Care Med</source>. <year>2011</year>;<volume>39</volume>(<issue>9</issue>):<fpage>2163</fpage>–<lpage>72</lpage>. Epub 2011/05/17. <comment>doi: </comment><pub-id pub-id-type="doi">10.1097/CCM.0b013e31821f0522</pub-id> .<?supplied-pmid 21572323?><pub-id pub-id-type="pmid">21572323</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0283748.ref003">
                <label>3</label>
                <mixed-citation publication-type="journal"><name><surname>Fernandez-Perez</surname><given-names>ER</given-names></name>, <name><surname>Sprung</surname><given-names>J</given-names></name>, <name><surname>Afessa</surname><given-names>B</given-names></name>, <name><surname>Warner</surname><given-names>DO</given-names></name>, <name><surname>Vachon</surname><given-names>CM</given-names></name>, <name><surname>Schroeder</surname><given-names>DR</given-names></name>, <etal>et al</etal>. <article-title>Intraoperative ventilator settings and acute lung injury after elective surgery: a nested case control study</article-title>. <source>Thorax</source>. <year>2009</year>;<volume>64</volume>(<issue>2</issue>):<fpage>121</fpage>–<lpage>7</lpage>. Epub 2008/11/08. <comment>doi: </comment><pub-id pub-id-type="doi">10.1136/thx.2008.102228</pub-id> .<?supplied-pmid 18988659?><pub-id pub-id-type="pmid">18988659</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0283748.ref004">
                <label>4</label>
                <mixed-citation publication-type="journal"><name><surname>Canet</surname><given-names>J</given-names></name>, <name><surname>Gallart</surname><given-names>L</given-names></name>, <name><surname>Gomar</surname><given-names>C</given-names></name>, <name><surname>Paluzie</surname><given-names>G</given-names></name>, <name><surname>Valles</surname><given-names>J</given-names></name>, <name><surname>Castillo</surname><given-names>J</given-names></name>, <etal>et al</etal>. <article-title>Prediction of postoperative pulmonary complications in a population-based surgical cohort</article-title>. <source>Anesthesiology</source>. <year>2010</year>;<volume>113</volume>(<issue>6</issue>):<fpage>1338</fpage>–<lpage>50</lpage>. Epub 2010/11/04. <comment>doi: </comment><pub-id pub-id-type="doi">10.1097/ALN.0b013e3181fc6e0a</pub-id> .<?supplied-pmid 21045639?><pub-id pub-id-type="pmid">21045639</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0283748.ref005">
                <label>5</label>
                <mixed-citation publication-type="journal"><name><surname>Lawrence</surname><given-names>VA</given-names></name>, <name><surname>Cornell</surname><given-names>JE</given-names></name>, <name><surname>Smetana</surname><given-names>GW</given-names></name>, <name><surname>American College of</surname><given-names>P</given-names></name>. <article-title>Strategies to reduce postoperative pulmonary complications after noncardiothoracic surgery: systematic review for the American College of Physicians</article-title>. <source>Ann Intern Med</source>. <year>2006</year>;<volume>144</volume>(<issue>8</issue>):<fpage>596</fpage>–<lpage>608</lpage>. Epub 2006/04/19. <comment>doi: </comment><pub-id pub-id-type="doi">10.7326/0003-4819-144-8-200604180-00011</pub-id> .<?supplied-pmid 16618957?><pub-id pub-id-type="pmid">16618957</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0283748.ref006">
                <label>6</label>
                <mixed-citation publication-type="journal"><name><surname>Qaseem</surname><given-names>A</given-names></name>, <name><surname>Snow</surname><given-names>V</given-names></name>, <name><surname>Fitterman</surname><given-names>N</given-names></name>, <name><surname>Hornbake</surname><given-names>ER</given-names></name>, <name><surname>Lawrence</surname><given-names>VA</given-names></name>, <name><surname>Smetana</surname><given-names>GW</given-names></name>, <etal>et al</etal>. <article-title>Risk assessment for and strategies to reduce perioperative pulmonary complications for patients undergoing noncardiothoracic surgery: a guideline from the American College of Physicians</article-title>. <source>Ann Intern Med</source>. <year>2006</year>;<volume>144</volume>(<issue>8</issue>):<fpage>575</fpage>–<lpage>80</lpage>. Epub 2006/04/19. <comment>doi: </comment><pub-id pub-id-type="doi">10.7326/0003-4819-144-8-200604180-00008</pub-id> .<?supplied-pmid 16618955?><pub-id pub-id-type="pmid">16618955</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0283748.ref007">
                <label>7</label>
                <mixed-citation publication-type="journal"><name><surname>Futier</surname><given-names>E</given-names></name>, <name><surname>Constantin</surname><given-names>JM</given-names></name>, <name><surname>Paugam-Burtz</surname><given-names>C</given-names></name>, <name><surname>Pascal</surname><given-names>J</given-names></name>, <name><surname>Eurin</surname><given-names>M</given-names></name>, <name><surname>Neuschwander</surname><given-names>A</given-names></name>, <etal>et al</etal>. <article-title>A trial of intraoperative low-tidal-volume ventilation in abdominal surgery</article-title>. <source>N Engl J Med</source>. <year>2013</year>;<volume>369</volume>(<issue>5</issue>):<fpage>428</fpage>–<lpage>37</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1056/NEJMoa1301082</pub-id> .<?supplied-pmid 23902482?><pub-id pub-id-type="pmid">23902482</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0283748.ref008">
                <label>8</label>
                <mixed-citation publication-type="journal"><name><surname>Ladha</surname><given-names>K</given-names></name>, <name><surname>Vidal Melo</surname><given-names>MF</given-names></name>, <name><surname>McLean</surname><given-names>DJ</given-names></name>, <name><surname>Wanderer</surname><given-names>JP</given-names></name>, <name><surname>Grabitz</surname><given-names>SD</given-names></name>, <name><surname>Kurth</surname><given-names>T</given-names></name>, <etal>et al</etal>. <article-title>Intraoperative protective mechanical ventilation and risk of postoperative respiratory complications: hospital based registry study</article-title>. <source>BMJ</source>. <year>2015</year>;<volume>351</volume>:<fpage>h3646</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1136/bmj.h3646</pub-id> .<?supplied-pmid 26174419?><pub-id pub-id-type="pmid">26174419</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0283748.ref009">
                <label>9</label>
                <mixed-citation publication-type="journal"><name><surname>de Jong</surname><given-names>MAC</given-names></name>, <name><surname>Ladha</surname><given-names>KS</given-names></name>, <name><surname>Vidal Melo</surname><given-names>MF</given-names></name>, <name><surname>Staehr-Rye</surname><given-names>AK</given-names></name>, <name><surname>Bittner</surname><given-names>EA</given-names></name>, <name><surname>Kurth</surname><given-names>T</given-names></name>, <etal>et al</etal>. <article-title>Differential Effects of Intraoperative Positive End-expiratory Pressure (PEEP) on Respiratory Outcome in Major Abdominal Surgery Versus Craniotomy.</article-title><source>Ann Surg</source>. <year>2016</year>;<volume>264</volume>(<issue>2</issue>):<fpage>362</fpage>–<lpage>9</lpage>. Epub 2015/10/27. <comment>doi: </comment><pub-id pub-id-type="doi">10.1097/SLA.0000000000001499</pub-id> ; PubMed Central PMCID: PMC4841734.<?supplied-pmid 26496082?><pub-id pub-id-type="pmid">26496082</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0283748.ref010">
                <label>10</label>
                <mixed-citation publication-type="journal"><name><surname>Fernandez-Bustamante</surname><given-names>A</given-names></name>, <name><surname>Wood</surname><given-names>CL</given-names></name>, <name><surname>Tran</surname><given-names>ZV</given-names></name>, <name><surname>Moine</surname><given-names>P</given-names></name>. <article-title>Intraoperative ventilation: incidence and risk factors for receiving large tidal volumes during general anesthesia.</article-title><source>BMC Anesthesiol.</source><year>2011</year>;<volume>11</volume>:<fpage>22</fpage>. Epub 2011/11/23. <comment>doi: </comment><pub-id pub-id-type="doi">10.1186/1471-2253-11-22</pub-id> ; PubMed Central PMCID: PMC3235523.<?supplied-pmid 22103561?><pub-id pub-id-type="pmid">22103561</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0283748.ref011">
                <label>11</label>
                <mixed-citation publication-type="journal"><name><surname>Grosse-Sundrup</surname><given-names>M</given-names></name>, <name><surname>Henneman</surname><given-names>JP</given-names></name>, <name><surname>Sandberg</surname><given-names>WS</given-names></name>, <name><surname>Bateman</surname><given-names>BT</given-names></name>, <name><surname>Uribe</surname><given-names>JV</given-names></name>, <name><surname>Nguyen</surname><given-names>NT</given-names></name>, <etal>et al</etal>. <article-title>Intermediate acting non-depolarizing neuromuscular blocking agents and risk of postoperative respiratory complications: prospective propensity score matched cohort study</article-title>. <source>BMJ</source>. <year>2012</year>;<volume>345</volume>:<fpage>e6329</fpage>. Epub 2012/10/19. <comment>doi: </comment><pub-id pub-id-type="doi">10.1136/bmj.e6329</pub-id> ; PubMed Central PMCID: PMC3473088.<?supplied-pmid 23077290?><pub-id pub-id-type="pmid">23077290</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0283748.ref012">
                <label>12</label>
                <mixed-citation publication-type="journal"><name><surname>Sasaki</surname><given-names>N</given-names></name>, <name><surname>Meyer</surname><given-names>MJ</given-names></name>, <name><surname>Malviya</surname><given-names>SA</given-names></name>, <name><surname>Stanislaus</surname><given-names>AB</given-names></name>, <name><surname>MacDonald</surname><given-names>T</given-names></name>, <name><surname>Doran</surname><given-names>ME</given-names></name>, <etal>et al</etal>. <article-title>Effects of neostigmine reversal of nondepolarizing neuromuscular blocking agents on postoperative respiratory outcomes: a prospective study</article-title>. <source>Anesthesiology</source>. <year>2014</year>;<volume>121</volume>(<issue>5</issue>):<fpage>959</fpage>–<lpage>68</lpage>. Epub 2014/09/17. <comment>doi: </comment><pub-id pub-id-type="doi">10.1097/ALN.0000000000000440</pub-id> .<?supplied-pmid 25225821?><pub-id pub-id-type="pmid">25225821</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0283748.ref013">
                <label>13</label>
                <mixed-citation publication-type="journal"><name><surname>Fuchs-Buder</surname><given-names>T</given-names></name>, <name><surname>Nemes</surname><given-names>R</given-names></name>, <name><surname>Schmartz</surname><given-names>D</given-names></name>. <article-title>Residual neuromuscular blockade: management and impact on postoperative pulmonary outcome.</article-title><source>Curr Opin Anaesthesiol</source>. <year>2016</year>;<volume>29</volume>(<issue>6</issue>):<fpage>662</fpage>–<lpage>7</lpage>. Epub 2016/10/19. <comment>doi: </comment><pub-id pub-id-type="doi">10.1097/ACO.0000000000000395</pub-id> .<?supplied-pmid 27755128?><pub-id pub-id-type="pmid">27755128</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0283748.ref014">
                <label>14</label>
                <mixed-citation publication-type="journal"><collab>Prove Network Investigators for the Clinical Trial Network of the European Society of Anaesthesiology</collab>, <name><surname>Hemmes</surname><given-names>SN</given-names></name>, <name><surname>Gama de Abreu</surname><given-names>M</given-names></name>, <name><surname>Pelosi</surname><given-names>P</given-names></name>, <name><surname>Schultz</surname><given-names>MJ</given-names></name>. <article-title>High versus low positive end-expiratory pressure during general anaesthesia for open abdominal surgery (PROVHILO trial): a multicentre randomised controlled trial</article-title>. <source>Lancet</source>. <year>2014</year>;<volume>384</volume>(<issue>9942</issue>):<fpage>495</fpage>–<lpage>503</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/S0140-6736(14)60416-5</pub-id> .<?supplied-pmid 24894577?><pub-id pub-id-type="pmid">24894577</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0283748.ref015">
                <label>15</label>
                <mixed-citation publication-type="journal"><name><surname>Guldner</surname><given-names>A</given-names></name>, <name><surname>Kiss</surname><given-names>T</given-names></name>, <name><surname>Serpa Neto</surname><given-names>A</given-names></name>, <name><surname>Hemmes</surname><given-names>SN</given-names></name>, <name><surname>Canet</surname><given-names>J</given-names></name>, <name><surname>Spieth</surname><given-names>PM</given-names></name>, <etal>et al</etal>. <article-title>Intraoperative protective mechanical ventilation for prevention of postoperative pulmonary complications: a comprehensive review of the role of tidal volume, positive end-expiratory pressure, and lung recruitment maneuvers</article-title>. <source>Anesthesiology</source>. <year>2015</year>;<volume>123</volume>(<issue>3</issue>):<fpage>692</fpage>–<lpage>713</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1097/ALN.0000000000000754</pub-id> .<?supplied-pmid 26120769?><pub-id pub-id-type="pmid">26120769</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0283748.ref016">
                <label>16</label>
                <mixed-citation publication-type="journal"><name><surname>Pereira</surname><given-names>SM</given-names></name>, <name><surname>Tucci</surname><given-names>MR</given-names></name>, <name><surname>Morais</surname><given-names>CCA</given-names></name>, <name><surname>Simoes</surname><given-names>CM</given-names></name>, <name><surname>Tonelotto</surname><given-names>BFF</given-names></name>, <name><surname>Pompeo</surname><given-names>MS</given-names></name>, <etal>et al</etal>. <article-title>Individual Positive End-expiratory Pressure Settings Optimize Intraoperative Mechanical Ventilation and Reduce Postoperative Atelectasis</article-title>. <source>Anesthesiology</source>. <year>2018</year>;<volume>129</volume>(<issue>6</issue>):<fpage>1070</fpage>–<lpage>81</lpage>. Epub 2018/09/28. <comment>doi: </comment><pub-id pub-id-type="doi">10.1097/ALN.0000000000002435</pub-id> .<?supplied-pmid 30260897?><pub-id pub-id-type="pmid">30260897</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0283748.ref017">
                <label>17</label>
                <mixed-citation publication-type="journal"><name><surname>Zhang</surname><given-names>C</given-names></name>, <name><surname>Xu</surname><given-names>F</given-names></name>, <name><surname>Li</surname><given-names>W</given-names></name>, <name><surname>Tong</surname><given-names>X</given-names></name>, <name><surname>Xia</surname><given-names>R</given-names></name>, <name><surname>Wang</surname><given-names>W</given-names></name>, <etal>et al</etal>. <article-title>Driving Pressure-Guided Individualized Positive End-Expiratory Pressure in Abdominal Surgery: A Randomized Controlled Trial.</article-title><source>Anesth Analg</source>. <year>2021</year>. Epub 2021/06/15. <comment>doi: </comment><pub-id pub-id-type="doi">10.1213/ANE.0000000000005575</pub-id> .<?supplied-pmid 34125080?><pub-id pub-id-type="pmid">34125080</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0283748.ref018">
                <label>18</label>
                <mixed-citation publication-type="journal"><name><surname>Wu</surname><given-names>XZ</given-names></name>, <name><surname>Xia</surname><given-names>HM</given-names></name>, <name><surname>Zhang</surname><given-names>P</given-names></name>, <name><surname>Li</surname><given-names>L</given-names></name>, <name><surname>Hu</surname><given-names>QH</given-names></name>, <name><surname>Guo</surname><given-names>SP</given-names></name>, <etal>et al</etal>. <article-title>Effects of ultrasound-guided alveolar recruitment manoeuvres compared with sustained inflation or no recruitment manoeuvres on atelectasis in laparoscopic gynaecological surgery as assessed by ultrasonography: a randomized clinical trial</article-title>. <source>BMC Anesthesiol</source>. <year>2022</year>;<volume>22</volume>(<issue>1</issue>):<fpage>261</fpage>. Epub 20220816. <comment>doi: </comment><pub-id pub-id-type="doi">10.1186/s12871-022-01798-z</pub-id> ; PubMed Central PMCID: PMC9380300.<?supplied-pmid 35974310?><pub-id pub-id-type="pmid">35974310</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0283748.ref019">
                <label>19</label>
                <mixed-citation publication-type="journal"><name><surname>Ferrando</surname><given-names>C</given-names></name>, <name><surname>Soro</surname><given-names>M</given-names></name>, <name><surname>Unzueta</surname><given-names>C</given-names></name>, <name><surname>Suarez-Sipmann</surname><given-names>F</given-names></name>, <name><surname>Canet</surname><given-names>J</given-names></name>, <name><surname>Librero</surname><given-names>J</given-names></name>, <etal>et al</etal>. <article-title>Individualised perioperative open-lung approach versus standard protective ventilation in abdominal surgery (iPROVE): a randomised controlled trial.</article-title><source>Lancet Respir Med.</source><year>2018</year>;<volume>6</volume>(<issue>3</issue>):<fpage>193</fpage>–<lpage>203</lpage>. Epub 2018/01/27. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/S2213-2600(18)30024-9</pub-id> .<?supplied-pmid 29371130?><pub-id pub-id-type="pmid">29371130</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0283748.ref020">
                <label>20</label>
                <mixed-citation publication-type="journal"><name><surname>Fernandez-Bustamante</surname><given-names>A</given-names></name>, <name><surname>Sprung</surname><given-names>J</given-names></name>, <name><surname>Parker</surname><given-names>RA</given-names></name>, <name><surname>Bartels</surname><given-names>K</given-names></name>, <name><surname>Weingarten</surname><given-names>TN</given-names></name>, <name><surname>Kosour</surname><given-names>C</given-names></name>, <etal>et al</etal>. <article-title>Individualized PEEP to optimise respiratory mechanics during abdominal surgery: a pilot randomised controlled trial</article-title>. <source>British journal of anaesthesia</source>. <year>2020</year>;<volume>125</volume>(<issue>3</issue>):<fpage>383</fpage>–<lpage>92</lpage>. Epub 2020/07/20. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.bja.2020.06.030</pub-id> ; PubMed Central PMCID: PMC7497030.<?supplied-pmid 32682559?><pub-id pub-id-type="pmid">32682559</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0283748.ref021">
                <label>21</label>
                <mixed-citation publication-type="journal"><name><surname>Yanez-Brage</surname><given-names>I</given-names></name>, <name><surname>Pita-Fernandez</surname><given-names>S</given-names></name>, <name><surname>Juffe-Stein</surname><given-names>A</given-names></name>, <name><surname>Martinez-Gonzalez</surname><given-names>U</given-names></name>, <name><surname>Pertega-Diaz</surname><given-names>S</given-names></name>, <name><surname>Mauleon-Garcia</surname><given-names>A</given-names></name>. <article-title>Respiratory physiotherapy and incidence of pulmonary complications in off-pump coronary artery bypass graft surgery: an observational follow-up study.</article-title><source>BMC pulmonary medicine</source>. <year>2009</year>;<volume>9</volume>:<fpage>36</fpage>. Epub 2009/07/30. <comment>doi: </comment><pub-id pub-id-type="doi">10.1186/1471-2466-9-36</pub-id> ; PubMed Central PMCID: PMC2727489.<?supplied-pmid 19638209?><pub-id pub-id-type="pmid">19638209</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0283748.ref022">
                <label>22</label>
                <mixed-citation publication-type="journal"><name><surname>Cassidy</surname><given-names>MR</given-names></name>, <name><surname>Rosenkranz</surname><given-names>P</given-names></name>, <name><surname>McCabe</surname><given-names>K</given-names></name>, <name><surname>Rosen</surname><given-names>JE</given-names></name>, <name><surname>McAneny</surname><given-names>D</given-names></name>. <article-title>I COUGH: reducing postoperative pulmonary complications with a multidisciplinary patient care program</article-title>. <source>JAMA Surg</source>. <year>2013</year>;<volume>148</volume>(<issue>8</issue>):<fpage>740</fpage>–<lpage>5</lpage>. Epub 2013/06/07. <comment>doi: </comment><pub-id pub-id-type="doi">10.1001/jamasurg.2013.358</pub-id> .<?supplied-pmid 23740240?><pub-id pub-id-type="pmid">23740240</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0283748.ref023">
                <label>23</label>
                <mixed-citation publication-type="journal"><name><surname>do Nascimento Junior</surname><given-names>P</given-names></name>, <name><surname>Modolo</surname><given-names>NS</given-names></name>, <name><surname>Andrade</surname><given-names>S</given-names></name>, <name><surname>Guimaraes</surname><given-names>MM</given-names></name>, <name><surname>Braz</surname><given-names>LG</given-names></name>, <name><surname>El Dib</surname><given-names>R</given-names></name>. <article-title>Incentive spirometry for prevention of postoperative pulmonary complications in upper abdominal surgery</article-title>. <source>The Cochrane database of systematic reviews</source>. <year>2014</year>;(2):CD006058. <comment>doi: </comment><pub-id pub-id-type="doi">10.1002/14651858.CD006058.pub3</pub-id> .<?supplied-pmid 24510642?><pub-id pub-id-type="pmid">24510642</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0283748.ref024">
                <label>24</label>
                <mixed-citation publication-type="journal"><name><surname>Ljungqvist</surname><given-names>O</given-names></name>, <name><surname>Scott</surname><given-names>M</given-names></name>, <name><surname>Fearon</surname><given-names>KC</given-names></name>. <article-title>Enhanced Recovery After Surgery: A Review.</article-title><source>JAMA Surg</source>. <year>2017</year>;<volume>152</volume>(<issue>3</issue>):<fpage>292</fpage>–<lpage>8</lpage>. Epub 2017/01/18. <comment>doi: </comment><pub-id pub-id-type="doi">10.1001/jamasurg.2016.4952</pub-id> .<?supplied-pmid 28097305?><pub-id pub-id-type="pmid">28097305</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0283748.ref025">
                <label>25</label>
                <mixed-citation publication-type="journal"><name><surname>Alawadi</surname><given-names>ZM</given-names></name>, <name><surname>Leal</surname><given-names>I</given-names></name>, <name><surname>Phatak</surname><given-names>UR</given-names></name>, <name><surname>Flores-Gonzalez</surname><given-names>JR</given-names></name>, <name><surname>Holihan</surname><given-names>JL</given-names></name>, <name><surname>Karanjawala</surname><given-names>BE</given-names></name>, <etal>et al</etal>. <article-title>Facilitators and barriers of implementing enhanced recovery in colorectal surgery at a safety net hospital: A provider and patient perspective</article-title>. <source>Surgery</source>. <year>2016</year>;<volume>159</volume>(<issue>3</issue>):<fpage>700</fpage>–<lpage>12</lpage>. Epub 20151002. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.surg.2015.08.025</pub-id> .<?supplied-pmid 26435444?><pub-id pub-id-type="pmid">26435444</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0283748.ref026">
                <label>26</label>
                <mixed-citation publication-type="journal"><name><surname>Fiore</surname><given-names>JF</given-names><suffix>Jr.</suffix></name>, <name><surname>Castelino</surname><given-names>T</given-names></name>, <name><surname>Pecorelli</surname><given-names>N</given-names></name>, <name><surname>Niculiseanu</surname><given-names>P</given-names></name>, <name><surname>Balvardi</surname><given-names>S</given-names></name>, <name><surname>Hershorn</surname><given-names>O</given-names></name>, <etal>et al</etal>. <article-title>Ensuring Early Mobilization Within an Enhanced Recovery Program for Colorectal Surgery: A Randomized Controlled Trial</article-title>. <source>Ann Surg</source>. <year>2017</year>;<volume>266</volume>(<issue>2</issue>):<fpage>223</fpage>–<lpage>31</lpage>. Epub 2016/12/21. <comment>doi: </comment><pub-id pub-id-type="doi">10.1097/SLA.0000000000002114</pub-id> .<?supplied-pmid 27997472?><pub-id pub-id-type="pmid">27997472</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0283748.ref027">
                <label>27</label>
                <mixed-citation publication-type="journal"><name><surname>Chan</surname><given-names>AW</given-names></name>, <name><surname>Tetzlaff</surname><given-names>JM</given-names></name>, <name><surname>Altman</surname><given-names>DG</given-names></name>, <name><surname>Laupacis</surname><given-names>A</given-names></name>, <name><surname>Gotzsche</surname><given-names>PC</given-names></name>, <name><surname>Krleza-Jeric</surname><given-names>K</given-names></name>, <etal>et al</etal>. <article-title>SPIRIT 2013 statement: defining standard protocol items for clinical trials</article-title>. <source>Ann Intern Med</source>. <year>2013</year>;<volume>158</volume>(<issue>3</issue>):<fpage>200</fpage>–<lpage>7</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.7326/0003-4819-158-3-201302050-00583</pub-id> ; PubMed Central PMCID: PMC5114123.<?supplied-pmid 23295957?><pub-id pub-id-type="pmid">23295957</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0283748.ref028">
                <label>28</label>
                <mixed-citation publication-type="journal"><name><surname>Butcher</surname><given-names>NJ</given-names></name>, <name><surname>Monsour</surname><given-names>A</given-names></name>, <name><surname>Mew</surname><given-names>EJ</given-names></name>, <name><surname>Chan</surname><given-names>AW</given-names></name>, <name><surname>Moher</surname><given-names>D</given-names></name>, <name><surname>Mayo-Wilson</surname><given-names>E</given-names></name>, <etal>et al</etal>. <article-title>Guidelines for Reporting Outcomes in Trial Protocols: The SPIRIT-Outcomes 2022 Extension.</article-title><source>JAMA</source>. <year>2022</year>;<volume>328</volume>(<issue>23</issue>):<fpage>2345</fpage>–<lpage>56</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1001/jama.2022.21243</pub-id> .<?supplied-pmid 36512367?><pub-id pub-id-type="pmid">36512367</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0283748.ref029">
                <label>29</label>
                <mixed-citation publication-type="journal"><name><surname>Castelino</surname><given-names>T</given-names></name>, <name><surname>Fiore</surname><given-names>JF</given-names><suffix>Jr</suffix></name>, <name><surname>Niculiseanu</surname><given-names>P</given-names></name>, <name><surname>Landry</surname><given-names>T</given-names></name>, <name><surname>Augustin</surname><given-names>B</given-names></name>, <name><surname>Feldman</surname><given-names>LS</given-names></name>. <article-title>The effect of early mobilization protocols on postoperative outcomes following abdominal and thoracic surgery: A systematic review</article-title>. <source>Surgery</source>. <year>2016</year>;<volume>159</volume>(<issue>4</issue>):<fpage>991</fpage>–<lpage>1003</lpage>. Epub 20160121. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.surg.2015.11.029</pub-id> .<?supplied-pmid 26804821?><pub-id pub-id-type="pmid">26804821</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0283748.ref030">
                <label>30</label>
                <mixed-citation publication-type="journal"><name><surname>Brull</surname><given-names>SJ</given-names></name>, <name><surname>Kopman</surname><given-names>AF</given-names></name>. <article-title>Current Status of Neuromuscular Reversal and Monitoring: Challenges and Opportunities</article-title>. <source>Anesthesiology</source>. <year>2017</year>;<volume>126</volume>(<issue>1</issue>):<fpage>173</fpage>–<lpage>90</lpage>. Epub 2016/11/08. <comment>doi: </comment><pub-id pub-id-type="doi">10.1097/ALN.0000000000001409</pub-id> .<?supplied-pmid 27820709?><pub-id pub-id-type="pmid">27820709</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0283748.ref031">
                <label>31</label>
                <mixed-citation publication-type="journal"><name><surname>Pasquina</surname><given-names>P</given-names></name>, <name><surname>Tramér</surname><given-names>MR</given-names></name>, <name><surname>Granier</surname><given-names>J-M</given-names></name>, <name><surname>Walder</surname><given-names>B</given-names></name>. <article-title>Respiratory Physiotherapy To Prevent Pulmonary Complications After Abdominal Surgery.</article-title><source>Chest</source>. <year>2006</year>;<volume>130</volume>(<issue>6</issue>):<fpage>1887</fpage>–<lpage>99</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1378/chest.130.6.1887</pub-id>
<?supplied-pmid 17167013?><pub-id pub-id-type="pmid">17167013</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0283748.ref032">
                <label>32</label>
                <mixed-citation publication-type="journal"><name><surname>Kroenke</surname><given-names>K</given-names></name>, <name><surname>Lawrence</surname><given-names>VA</given-names></name>, <name><surname>Theroux</surname><given-names>JF</given-names></name>, <name><surname>Tuley</surname><given-names>MR</given-names></name>. <article-title>Operative risk in patients with severe obtructive pulmonary disease</article-title>. <source>Archives of internal medicine</source>. <year>1992</year>;<volume>152</volume>(<issue>5</issue>):<fpage>967</fpage>–<lpage>71</lpage>.<pub-id pub-id-type="pmid">1580723</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0283748.ref033">
                <label>33</label>
                <mixed-citation publication-type="journal"><name><surname>Hulzebos</surname><given-names>EH</given-names></name>, <name><surname>Helders</surname><given-names>PJ</given-names></name>, <name><surname>Favie</surname><given-names>NJ</given-names></name>, <name><surname>De Bie</surname><given-names>RA</given-names></name>, Brutel de la Riviere A, Van Meeteren NL. <article-title>Preoperative intensive inspiratory muscle training to prevent postoperative pulmonary complications in high-risk patients undergoing CABG surgery: a randomized clinical trial</article-title>. <source>JAMA</source>. <year>2006</year>;<volume>296</volume>(<issue>15</issue>):<fpage>1851</fpage>–<lpage>7</lpage>. Epub 2006/10/19. <comment>doi: </comment><pub-id pub-id-type="doi">10.1001/jama.296.15.1851</pub-id> .<?supplied-pmid 17047215?><pub-id pub-id-type="pmid">17047215</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0283748.ref034">
                <label>34</label>
                <mixed-citation publication-type="journal"><name><surname>Fernandez-Bustamante</surname><given-names>A</given-names></name>, <name><surname>Frendl</surname><given-names>G</given-names></name>, <name><surname>Sprung</surname><given-names>J</given-names></name>, <name><surname>Kor</surname><given-names>DJ</given-names></name>, <name><surname>Subramaniam</surname><given-names>B</given-names></name>, <name><surname>Martinez Ruiz</surname><given-names>R</given-names></name>, <etal>et al</etal>. <article-title>Postoperative Pulmonary Complications, Early Mortality, and Hospital Stay Following Noncardiothoracic Surgery: A Multicenter Study by the Perioperative Research Network Investigators.</article-title><source>JAMA Surg</source>. <year>2017</year>;<volume>152</volume>(<issue>2</issue>):<fpage>157</fpage>–<lpage>66</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1001/jamasurg.2016.4065</pub-id> ; PubMed Central PMCID: PMC5334462.<?supplied-pmid 27829093?><pub-id pub-id-type="pmid">27829093</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0283748.ref035">
                <label>35</label>
                <mixed-citation publication-type="journal"><name><surname>Rackley</surname><given-names>CR</given-names></name>, <name><surname>Levitt</surname><given-names>JE</given-names></name>, <name><surname>Zhuo</surname><given-names>H</given-names></name>, <name><surname>Matthay</surname><given-names>MA</given-names></name>, <name><surname>Calfee</surname><given-names>CS</given-names></name>. <article-title>Clinical evidence of early acute lung injury often precedes the diagnosis of ALI</article-title>. <source>J Intensive Care Med</source>. <year>2013</year>;<volume>28</volume>(<issue>4</issue>):<fpage>241</fpage>–<lpage>6</lpage>. Epub 20120624. <comment>doi: </comment><pub-id pub-id-type="doi">10.1177/0885066612450850</pub-id> ; PubMed Central PMCID: PMC3482421.<?supplied-pmid 22733725?><pub-id pub-id-type="pmid">22733725</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0283748.ref036">
                <label>36</label>
                <mixed-citation publication-type="journal"><name><surname>Mazo</surname><given-names>V</given-names></name>, <name><surname>Sabate</surname><given-names>S</given-names></name>, <name><surname>Canet</surname><given-names>J</given-names></name>, <name><surname>Gallart</surname><given-names>L</given-names></name>, <name><surname>de Abreu</surname><given-names>MG</given-names></name>, <name><surname>Belda</surname><given-names>J</given-names></name>, <etal>et al</etal>. <article-title>Prospective external validation of a predictive score for postoperative pulmonary complications</article-title>. <source>Anesthesiology</source>. <year>2014</year>;<volume>121</volume>(<issue>2</issue>):<fpage>219</fpage>–<lpage>31</lpage>. Epub 2014/06/06. <comment>doi: </comment><pub-id pub-id-type="doi">10.1097/ALN.0000000000000334</pub-id> .<?supplied-pmid 24901240?><pub-id pub-id-type="pmid">24901240</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0283748.ref037">
                <label>37</label>
                <mixed-citation publication-type="journal"><name><surname>McAlister</surname><given-names>FA</given-names></name>, <name><surname>Bertsch</surname><given-names>K</given-names></name>, <name><surname>Man</surname><given-names>J</given-names></name>, <name><surname>Bradley</surname><given-names>J</given-names></name>, <name><surname>Jacka</surname><given-names>M</given-names></name>. <article-title>Incidence of and risk factors for pulmonary complications after nonthoracic surgery</article-title>. <source>Am J Respir Crit Care Med</source>. <year>2005</year>;<volume>171</volume>(<issue>5</issue>):<fpage>514</fpage>–<lpage>7</lpage>. Epub 20041124. <comment>doi: </comment><pub-id pub-id-type="doi">10.1164/rccm.200408-1069OC</pub-id> .<?supplied-pmid 15563632?><pub-id pub-id-type="pmid">15563632</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0283748.ref038">
                <label>38</label>
                <mixed-citation publication-type="journal"><name><surname>Fernandez-Bustamante</surname><given-names>A</given-names></name>, <name><surname>Klawitter</surname><given-names>J</given-names></name>, <name><surname>Repine</surname><given-names>JE</given-names></name>, <name><surname>Agazio</surname><given-names>A</given-names></name>, <name><surname>Janocha</surname><given-names>AJ</given-names></name>, <name><surname>Shah</surname><given-names>C</given-names></name>, <etal>et al</etal>. <article-title>Early effect of tidal volume on lung injury biomarkers in surgical patients with healthy lungs</article-title>. <source>Anesthesiology</source>. <year>2014</year>;<volume>121</volume>(<issue>3</issue>):<fpage>469</fpage>–<lpage>81</lpage>. Epub 2014/05/09. <comment>doi: </comment><pub-id pub-id-type="doi">10.1097/ALN.0000000000000301</pub-id> ; PubMed Central PMCID: PMC4165799.<?supplied-pmid 24809976?><pub-id pub-id-type="pmid">24809976</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0283748.ref039">
                <label>39</label>
                <mixed-citation publication-type="journal"><name><surname>Serpa Neto</surname><given-names>A</given-names></name>, <name><surname>Campos</surname><given-names>PP</given-names></name>, <name><surname>Hemmes</surname><given-names>SN</given-names></name>, <name><surname>Bos</surname><given-names>LD</given-names></name>, <name><surname>Bluth</surname><given-names>T</given-names></name>, <name><surname>Ferner</surname><given-names>M</given-names></name>, <etal>et al</etal>. <article-title>Kinetics of plasma biomarkers of inflammation and lung injury in surgical patients with or without postoperative pulmonary complications</article-title>. <source>European journal of anaesthesiology</source>. <year>2017</year>;<volume>34</volume>(<issue>4</issue>):<fpage>229</fpage>–<lpage>38</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1097/EJA.0000000000000614</pub-id> .<?supplied-pmid 28187051?><pub-id pub-id-type="pmid">28187051</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0283748.ref040">
                <label>40</label>
                <mixed-citation publication-type="journal"><name><surname>Parsons</surname><given-names>PE</given-names></name>, <name><surname>Eisner</surname><given-names>MD</given-names></name>, <name><surname>Thompson</surname><given-names>BT</given-names></name>, <name><surname>Matthay</surname><given-names>MA</given-names></name>, <name><surname>Ancukiewicz</surname><given-names>M</given-names></name>, <name><surname>Bernard</surname><given-names>GR</given-names></name>, <etal>et al</etal>. <article-title>Lower tidal volume ventilation and plasma cytokine markers of inflammation in patients with acute lung injury</article-title>. <source>Crit Care Med</source>. <year>2005</year>;<volume>33</volume>(<issue>1</issue>):<fpage>1</fpage>–<lpage>6</lpage>; discussion 230–2. Epub 2005/01/13. <comment>doi: </comment><pub-id pub-id-type="doi">10.1097/01.ccm.0000149854.61192.dc</pub-id> [pii]. .<?supplied-pmid 15644641?><pub-id pub-id-type="pmid">15644641</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0283748.ref041">
                <label>41</label>
                <mixed-citation publication-type="journal"><name><surname>Orkin</surname><given-names>AM</given-names></name>, <name><surname>Gill</surname><given-names>PJ</given-names></name>, <name><surname>Ghersi</surname><given-names>D</given-names></name>, <name><surname>Campbell</surname><given-names>L</given-names></name>, <name><surname>Sugarman</surname><given-names>J</given-names></name>, <name><surname>Emsley</surname><given-names>R</given-names></name>, <etal>et al</etal>. <article-title>Guidelines for Reporting Trial Protocols and Completed Trials Modified Due to the COVID-19 Pandemic and Other Extenuating Circumstances: The CONSERVE 2021 Statement.</article-title><source>JAMA</source>. <year>2021</year>;<volume>326</volume>(<issue>3</issue>):<fpage>257</fpage>–<lpage>65</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1001/jama.2021.9941</pub-id> .<?supplied-pmid 34152382?><pub-id pub-id-type="pmid">34152382</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0283748.ref042">
                <label>42</label>
                <mixed-citation publication-type="journal"><name><surname>Fontanarosa</surname><given-names>P</given-names></name>, <name><surname>Bauchner</surname><given-names>H</given-names></name>, <name><surname>Flanagin</surname><given-names>A</given-names></name>. <article-title>Authorship and Team Science.</article-title><source>JAMA</source>. <year>2017</year>;<volume>318</volume>(<issue>24</issue>):<fpage>2433</fpage>–<lpage>7</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1001/jama.2017.19341</pub-id> .<?supplied-pmid 29279909?><pub-id pub-id-type="pmid">29279909</pub-id></mixed-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
